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ABSTRACT 
There are two major challenges in nucleic acid X-ray crystallography: crystallization and 
phasing determination. With the introduction of selenium modification, the phasing problem can 
be solved rationally, while the crystallization problem can be solved partially. By taking advantage 
of the selenium modification, herein we report the synthesis of the Se-DNAs and the 
thermostability and crystallization study of the DNA-small molecule complexes. 5-Se-thymidine 
was successfully synthesized and incorporated into DNA oligonucleotides via solid-phase 
synthesis in order to facilitate the crystallization and phasing. The UV-melting study reveals that 
the selenium modification has caused no significate perturbation to the DNA stability. The small 
molecules (DB2429 and DB2457) were co-crystalized with Se-DNAs and the Se-DNA crystals 
were obtained, which are better than the native ones. In addition, our research suggested that the 
DNA oligonucleotides with the 5’-overhang form better crystals than those with the 3’-overhang 
or non-overhang. Our X-ray diffraction study is in progress. 
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1 INTRODUCTION  
1.1 Introduction of Central Dogma and Nucleic Acid Inhibition  
Nucleic acids are macromolecules that store and transfer genetic information in 
cells. They are ubiquitous in living systems. Nucleic acids, in the form of DNA and RNA, 
play important roles in central dogma, controlling the synthesis of proteins from the origin1-
3. Inhibition of nucleic acid activities can allow disease intervention. Therefore, nucleic 
acid molecules have become important drug targets4, 5. Unlike targeting proteins, inhibiting 
nucleic acids offers great advantages: sequence-based targeting, understanding of the 
underlying causes of diseases (such as gene expression disorders, viral infections and 
cancer)5-7, and easy design of drugs with high specificity. 
 
Figure 1.1 Schematic diagram of the central dogma. The solid arrows indicate the 
direction in which genetic information is transmitted under normal conditions, and the 
dashed arrows indicate the direction in which information is transmitted under 
unconventional circumstances. 
 
Recently, it has been found that functional nucleic acids (such as ribozyme and 
DNazyme) can catalyze chemical and biochemical reactions like proteins3, 8-10. The 
functional nucleic acids, e.g., ribozymes, DNazymes, antisense nucleic acid molecules, 
anti-gene sequences, nucleic acid aptamers, and small interfering RNAs3, 11, can also be 
used as drugs to inhibit nucleic acids for treating diseases. Likewise, small molecules can 
be designed to inhibit nucleic acids. 
DNA RNA Protein 
DNA Replication 
Transcription 
Reverse Transcription 
RNA Replication 
Translation 
16 
Small molecules that recognize mixed base pairs nucleic acid sequences can be 
used as transcription factor inhibitors by binding to a DNA promoter sequence rather than 
by targeting the transcription factor part of the complex. The applications of gene specific 
probes of this type are almost infinite. 
To further understand the inhibition of functional nucleic acids and small molecules, 
the study of the three-dimensional structure of nucleic acids, nucleic acid-small molecules 
and nucleic acid-protein complexes by X-ray crystallography is important and has become 
a very active research field. Our laboratory has found that selenium modification of nucleic 
acids can facilitate crystallization and phasing for nucleic acid structure determination. 
Therefore, by introducing selenium modification, we have investigated the Se-
derivatization and crystallization to accelerate the crystal structure determination of DNA-
small molecule complexes.3 
1.2 Introduction of X-ray Crystallography  
1.2.1 The function and application of X-ray crystallography 
Proteins and nucleic acids (especially RNA) can fold into complicated three-
dimensional structures12. The structural information of nucleic acids is essential for gaining 
insight into their biological functions. For example, after tRNA discovery, its role has been 
a mystery for a long time13. Until 1974, the X-ray crystal structure of L-shaped tRNA was 
successfully determined, and the mechanism of tRNA in protein biosynthesis was 
gradually revealed13-15. Over the past two decades, due to advances in X-ray diffraction 
crystallography, such as the development of crystallization science, the leap of synchrotron 
performance, and the use of more advanced purification equipment, nucleic acid structure 
detection has also been rapidly developed16. Consequently, more and more nucleic acid 
17 
molecules with high-resolution structures have been discovered, especially non-coding 
RNA molecules. At present, a large number of non-coding regulatory RNAs have been 
discovered, such as ribozymes17, nucleic acid switches18, and so on. In addition, there are 
many technological advances on potential nucleic acid therapeutics19, including antisense 
oligonucleotide chains, small interfering RNAs, microRNAs20, and aptamers. These 
studies demand advancements of structural and functional study of nucleic acids. Therefore, 
new methods, especially new nucleic acid X-ray crystallographic techniques (such as 
selenium modification), are urgently needed5. 
1.2.2 Challenges and difficulties in nucleic acid X-ray crystallography 
There are two bottlenecks in X-ray crystallography research itself: crystallization 
and phase problem. These two bottlenecks much limit the discovery of new structures and 
folding states of biological macromolecules (such as proteins and nucleic acids) and the 
exploration of biological mechanisms3. 
Compared to protein crystallography, nucleic acid X-ray crystallography has its 
unique challenges and difficulties. The first is the crystallization of nucleic acids. A crystal 
is a combination of a large number of molecules arranged in regular order, and the 
molecules are grouped by non-covalent bonds21. The surface of a protein molecule has a 
variety of structural and chemical groups that enable it to produce intermolecular 
interactions that facilitate crystal growth. The surface of the nucleic acid molecule is 
covered with dense, negatively charged phosphate groups, which makes it more difficult 
to crystallize into agglomerates. The second difficulty is that the method of rationally 
solving the phase problem of nucleic acid crystals has not been well developed so far. In 
general, crystallographic phase problems can be solved in several different ways. The 
18 
phase is determined by multi-wavelength anomalous diffraction (MAD) or single-
wavelength anomalous diffraction (SAD)3. For example, the study of selenomethionine-
derived proteins is the most successful and reasonable method to solve the phase problem 
of new protein crystal structure22. Currently, more than two-thirds of novel proteins are 
structurally determined by this method23. If a similar structure can be obtained, the phase 
problem of the protein structure can also be solved by molecular replacement24. However, 
it is somewhat difficult to determine the structure of a nucleic acid molecule having a 
highly repetitive unit by molecular replacement25. Heavy metal cation soaking and co-
crystallization have also been successfully applied to protein crystallization, while nucleic 
acid molecules with a phosphate backbone are often randomly hydrolyzed under these 
conditions. Halogen-derived nucleic acid molecules can cause nucleic acid structure 
perturbations and radiation instability. Therefore, due to the lack of convenient and stable 
massive atom derivatives, the phase problem of nucleic acid is still a considerable 
problem16. In addition to these two major challenges, there are other challenges in nucleic 
acid crystallography. For example, it is difficult to obtain consistent and conformational 
samples for crystallization and structural studies. In vitro enzymatic synthesis of DNA 
sequences over 50 nt (e.g., larger non-coding RNA) produces significant heterogeneity. 
Enzymatically synthesized nucleic acid sequences typically carry the 3'-end and/or 5'-end 
heterogeneity that is undesired by high-resolution structural analysis. The multi-step 
purification process is complicated and inefficient26. To increase the homogeneity of the 
transcribed RNA and increase the transcription efficiency, the 2'-methylated DNA of the 
last two nucleotides of the 5'-end was reported as a highly efficient template27. Another 
difficulty in nucleic acid crystallography is the heterogeneity of the structure. Because a 
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nucleic acid molecule (especially RNA) can be folded into many different three-
dimensional conformations21. In this case, it is necessary to find suitable refolding 
conditions in order to obtain conformationally homogenized molecules for crystal 
screening and structural studies. In order to solve all the above challenges and difficulties, 
our group pioneered and developed a selenium nucleic acid (SeNA) strategy that rationally 
solves the phase problem in nucleic acid crystallography5, 28-30. 
1.3 Introduction of Selenium Nucleic Acid 
1.3.1 The chemical and biochemical properties of selenium 
Selenium (Se), like the oxygen and sulfur, is located in the sixth main group of the 
periodic table. Therefore, their chemical properties are very similar, and there is a 
possibility of mutual substitution. Although as early as 1817, selenium was discovered by 
Jons Jakob Berzelius in plants enriched in selenium31. However, due to the toxicity of 
selenium itself, there is seldom research work on it in the early years. Between the 1930s 
and the 1950s, animal nutritionists and chemists had a great interest and curiosity about the 
structure and function of selenium-containing compounds in selenium-containing plants32. 
But unfortunately, these studies were not very successful and failed to identify any 
selenium-containing compounds. This is most likely because these compounds are unstable 
under separation conditions. Since the mid-1950s, the presence of selenium in proteins and 
the critical role that selenium plays in a series of physiological processes have been 
discovered, and research fields related to selenium have gradually attracted more and more 
attention from scientists3, 33, 34. 
Although it is toxic in the case of large intakes (it could cause selenium poisoning 
if selenium intake exceeds 400 mg per day), selenium is widely recognized as a vital trace 
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element35. Some plants are enriched in specific concentrations of selenium at individual 
sites and are somewhat toxic to prevent them from being eaten by animals. Some plants, 
such as mad grass, require selenium to grow, and their growth status can indicate the 
presence and content of selenium in the soil36. It is also a constituent of the unnatural amino 
acids selenocysteine and selenomethionine. In humans, selenium-containing compounds 
can also act as cofactors for the reduction of antioxidant enzymes, such as glycoperoxidase 
and some forms of thioredoxin reductase found in animals and some plants (these enzymes 
are present in all organisms, but only some plants require selenium-containing 
compounds)37-39. As a cofactor for three known thyroid deiodinases, selenium-containing 
compounds also play an essential role in goiter. The further influence of selenium-
containing compounds on human health, such as cancer, AIDS, tuberculosis, and diabetes, 
is still controversial, and research work in this area is continuing40. In general, selenium in 
the daily diet is mainly derived from nuts, grains, meat, fish, and eggs. 
Like oxygen atoms (atomic radius 0.73 Å) and sulfur atoms (atomic radius 1.02 Å), 
because of their similar chemical properties and electron distribution, in addition to 
proteins, selenium atoms (atomic radius 1.16 Å) are also used in several transport RNAs. 
Find. The predominant forms of selenium in natural transport RNA are 2-selenium-uridine 
and 5-methylaminomethyl-2-selenour41. The selenium-modified uridine 2-position 
selenium atom is introduced by the substitution of the 2-sulfur-uridine sulfur atom on the 
transport RNA under the action of 2-selenium-uridine synthase. The selenium atom donor 
is selenium phosphate42, 43. Selenium provides many unique biochemical and biological 
functions and properties for RNA and protein. There are approximately 23 known 
selenium-containing proteins in mammals44. In most selenium-containing enzymes, 
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selenium is present in the form of a selenocysteine residue. Selenocysteine is considered 
to be the 21st natural amino acid present in all organisms45. Also because of its large size 
and chemical and electronic arrangement properties, selenium is found in the anti-codon 
swing site of several bacterial transfer RNAs in the form of 5-methylamino-2-selenouridine, 
including Lysine transfer RNA, glutamate transfer RNA, and glutamine transfer RNA46. 
The function of the 2-position selenium atom of these modified nucleic acids is likely to 
increase the speed and efficiency of the translation process. In vivo observations indicate 
that selenium atoms can provide many useful and unique properties to natural RNA. 
Because the mechanism of selenium modification of transfer RNA is still a mystery, 
understanding the presence and function of selenium in proteins can be useful information 
and inspiration for the functional study of selenium-modified RNA. Selenium atoms in 
selenocysteine provide proteins with many unique properties different from oxygen and 
sulfur47, 48. The most intuitive difference is that SeH with selenocysteine (pKa value of 5.2) 
has a lower pKa value and a higher reduction potential than SH with a thiocysteine (pKa 
value of 8.5)49, 50. Thus, at physiological pH, selenocysteine has stronger nucleophilicity 
and better reducibility than native cysteine. These differences are the most fundamental 
reason to explain the existence of selenocysteine in proteins, especially redox proteins, 
because its presence can significantly increase the efficiency of redox reactions51, 52. 
Selenium plays a significant role in the redox centers of several important 
oxidoreductases53. Compared to a large amount of research work on naturally occurring 
selenium-containing modified proteins, the study of selenium-modified naturally occurring 
RNA appears to be very limited. Because selenium-modified RNA is difficult to obtain, 
and the research is challenging. At the same time, the exciting research and development 
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of selenium-modified proteins has also stimulated the synthesis and research of naturally 
occurring and non-natural selenium-modified RNAs. 
1.3.2 Introduction of 5-Se-Tymidine modified nucleic acid 
Because there are plenty of oxygen atoms can be modified in the nucleoside 
molecule, the direct selenium modification method for nucleic acids can be varied 
depending on the needs of the chemical system54. My research mainly focuses on the 
crystallization and structural studies of DNA containing 5-position selenium-modified 
thymidine. 
The hydrogen bond is the interaction between the hydrogen bond acceptor and the 
donor (X-H). In the hydrogen bond in the conventional sense, X refers to an electron-
positive atom (oxygen atom, nitrogen atom, etc.). However, in recent studies, when X is 
an electron-negative atom (such as a carbon atom), the hydrogen bond it generates is more 
and more accepted and valued, such as hydrogen bonds in CH···O=C55-58. Interaction of 
CH groups with hydrogen bond acceptors (electron donors), such as CH···O=C hydrogen 
bonds in proteins56, CH···O=C hydrogen bonds in uracil crystals58, and host-guest systems 
CH···Cl hydrogen bonds59 and other non-traditional interactions (such as CH···π 
interactions in RNA)60 which plays a vital role in molecular recognition, catalysis, and 
DNA double-strand stability in chemical and biological systems61, 62. Because the 
negatively charged phosphate group is an excellent electron donor, and phosphorylation 
and dephosphorylation are ubiquitous processes in the cell-regulatory mechanism63. Our 
group studied the synthesis of a thymidine (5-Se-T) by introducing an atom probe (a 
selenium atom) outside the 5-position of a heterocyclic base. The hydrogen bond 
interaction between the 5-position methyl group of thymidine and its phosphate backbone 
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(hydrogen bond interaction of CH···O--PO3) exists54. The first synthesis of 5-position 
methyl selenium modified thymidine was achieved via a method for introducing into 3',5'-
dibenzoyl-2'-deoxyuridine by electrophilic addition reaction through Mn(OAc)3 assisted 
CH3SeSeCH3. The 5-position methyl selenide-modified thymidine dephosphoramidite 
monomer was subsequently successfully synthesized and yielded a yield of more than 99% 
during the coupling of DNA synthesis. Biophysical and structural studies of thymidine-
modified DNA containing 5-methylselenolenium revealed that Se-modified DNA and 
almost unmodified DNA are almost identical. At the same time, the structural analysis of 
the crystallography of the thymidine modified by 5-methyl-selenium clearly indicates that 
there is a hydrogen bond between the 5-methyl group and the 5'-position phosphate group 
(CH3···PO4- interaction)54. 
In the double-stranded DNA molecule64, the 5-position methyl group of the 
thymidine is usually at a distance of 4 to 5 Å from the nearest oxygen atom on the 5'-
position phosphate group (O--PO3). In order to further extend the methyl group to bring it 
closer to the phosphate group and at the same time increase the rotational flexibility of the 
methyl group, an atomic bond is introduced between the methyl group of the thymidine 
and the 5-position carbon atom65, 66. If the methyl and phosphate groups (O--PO3) are 
capable of forming a real hydrogen bond, they can be observed in the crystal structure to 
be close to each other, and the density of electron clouds in between them will be high. If 
there is no such stable interaction between them, the steric hindrance forces the methyl 
group to be more prone to rotation away from the phosphate group and to the direction of 
the major groove. Since the position and spatial geometry of atoms and radicals have a 
significant influence in this experimental study, it is chosen to insert a selenium atom 
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between the 5-position methyl group and the 5-position carbon atom as an atom probe. And 
a brand new methyl-hydrogen phosphate bond (C-H···O--PO3) is successfully discovered 
54. 
1.3.3 Application of selenium nucleic acid in X-ray crystallography 
As mentioned above, in crystal diffraction, selenium atoms can provide an 
abnormal dispersion of electron centers, which can solve the phase problem well. The 
selenomethionine (Se-Met) modification revolutionized the X-ray crystallography of 
proteins. Especially after MAD analysis of selenomethionine-modified RNase H to 
successfully obtain its crystal structure, this method is increasingly favored by researchers. 
It is estimated that more than two-thirds of newly discovered protein structures are phased 
by the Se-Met MAD method3, 5. Similarly, although somewhat time-consuming and labor 
intensive, methods for determining the phase of nucleic acids by selenium-modified 
proteins bound to nucleic acids have also been developed. Inspired by the revolutionary 
advancement of protein X-ray crystallography by the substitution of sulfur atoms with 
selenium atoms, our group pioneered the method of determining the phase and crystal 
structure by replacing oxygen atoms at different positions in the nucleic acid with selenium 
atoms. 
This method of selenium modification has excellent potential for the study of the 
structure and function of accounting. So far, studies have shown that the crystal samples 
obtained by this method are more stable under X-ray irradiation than the conventional 
bromine atom modification method67. At the same time, the selenium atom modification 
method has more options than some limitations of the bromine modification method, 
because many oxygen atoms in the nucleic acid molecule can be substituted. Also, based 
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on the basic X-ray diffraction phase calculation, a modification of a selenium atom can 
determine the phase of a 30 or more base DNA or RNA sequence68. Since the selenium 
element and the oxygen element are located in the sixth main group of the periodic table, 
it is possible to achieve a very significant change in the structure of the nucleic acid 
molecule after replacing the oxygen atom with the selenium atom. In fact, this new 
modification method has been used in many laboratories for X-ray diffraction 
crystallography to analyze the molecular structure of DNA or RNA, such as ribozymes, 
human DNA, and riboswitches69, 70. In order to further optimize this method, an enzymatic 
process for preparing a selenium-modified nucleic acid molecule by a DNA synthase and 
an RNA transcriptase has emerged71. 
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2 EXPERIMENT 
2.1 The Synthesis of 5-Se-T phosphorimidite Starting with 5’-DMTr-5-I-dU 
Depending on the starting reactant, there are two different synthetic routes to 
prepare 5-Se-thymidine-phosphoramidite, via the reaction with 5'-dimethoxytrityl-5-
iododeoxyuridine or 5-iododeoxyuridine as the initial reactant. Both routes have their 
advantages and should be selected according to specific experimental needs54, 72. 
 
Figure 2.1 Schematic diagram of the synthetic route of 5'-dimethoxytrityl-5-
methylselenodeoxyuridine phosphoramidite with 5'-dimethoxytrityl-5-iodo-deoxyuridine 
as initial reactant. 
 
The synthesis route of 5'-dimethoxytrityl-5-methylselenodeoxyuridine 
phosphoramidite with 5'-dimethoxytrityl-5-iodo-deoxyuridine (5'-DMTr-5-I-dU) as initial 
reactant is shown in Figure 2.1. There are four steps in the route including tert-
butyldimethylsilyl-(TBDMS-) protection, the introduction of methyl selenium, 
detritylation, and the synthesis of phosphoramidite. 
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2.1.1 Tert-butyldimethylsilyl-(TBDMS-) protection 
The hydroxyl group at the 3'-position in the starting material is a good nucleophile. 
To avoid its influence on the subsequent introduction of methyl selenium, it is necessary 
to protect it with tert-butyldimethylsilyl group54, 72. 
2.1.1.1 Experimental procedure 
 
Figure 2.2 The reaction equation for the tert-butyldimethylsilyl protection reaction. 
 
The reaction equation of 3’-DMTr-5-Iodo-dU (Compound 1) protection step is 
shown in Figure 2.2. 1 g of Compound 1 was mixed with 408.6 mg of imidazole in a 25 
mL round bottom flask. 452.1 mg TBDMS-Cl was placed in another 10 mL round bottom 
flask. The flasks were dried over high vacuum for 30 min. The flasks were purged with 
argon and an argon balloon was placed to maintain constant pressure and to ensure an argon 
atmosphere during the reaction. TBDMS-Cl was dissolved in 7.5 mL of anhydrous DMF, 
and a DMF solution of TBDMS-Cl was added dropwise to a round bottom flask containing 
Compound 1 and imidazole. The reaction was stirred at room temperature overnight. The 
progress of the reaction was monitored by TLC. The TLC eluent was a mixed solution of 
ethyl acetate and hexane 1:2. After the reaction was completed, the reaction was quenched 
by the addition of 0.7 mL of methanol. The reaction solution was diluted with ethyl acetate 
and washed with water to remove DMF and other water-soluble impurities. The aqueous 
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phase was extracted three times with ethyl acetate, the aqueous phase was discarded and 
the organic phases were combined. The organic phase was washed three times with 
saturated brine and the aqueous phase was discarded. The organic phase is dried over 
anhydrous magnesium sulfate. After filtration and rotary evaporation, a crude product was 
gained. Further purification using a silica gel column yields a product of higher purity. The 
eluent of the silica gel column was a mixed solution of ethyl acetate and hexane 1:4. It 
should be noted that dimethoxytrityl-(DMTr-)group is unstable under acidic conditions and 
easily falls off into carbon cations. Since TBDMS-Cl is acidic, it cannot be mixed with 
Compound 1. In addition, when purifying the silica gel column, a base such as N,N-
dimethylethylamine should be used to neutralize the silica gel.  
The yield for this step is about 90%. 
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2.1.1.2 Proposed mechanism 
 
Figure 2.3 Reaction mechanism of tert-butyldimethylsilyl protection reaction. 
 
The reaction mechanism of this step is shown in Figure 2.3. First, the imidazole 
replaces the chlorine atom of TBDMS-Cl to form a better leaving group, thereby activating 
the silicon atom. Then, the hydroxyl group at the 3'-position of the sugar ring attacks the 
silicon atom to undergo a substitution reaction. The role of imidazole in the reaction 
process is the catalyst and proton acceptor. 
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2.1.2 The introduction of methyl selenium 
2.1.2.1 Experimental procedure 
 
Figure 2.4 Reaction equation for introducing methyl selenium reaction. 
 
The reaction equation of selenium introduction to 3’-DMTr-5’-TBDMS-5-Iodo-dU 
(Compound 2) reaction is shown in Figure 2.4. 500 mg of Compound 2 was weighed into 
a 25 mL round bottom flask. Another 23.4 mg of sodium hydride was weighed into another 
25 mL round bottom flask. The flasks were dried over high vacuum for 30 min. The flasks 
were purged with argon and an argon balloon was placed to maintain constant pressure and 
to ensure an argon atmosphere during the reaction. Compound 2 was dissolved in 7.5 mL 
of anhydrous tetrahydrofuran treated with sodium metal, and a solution of Compound 2 in 
tetrahydrofuran was added dropwise to a round bottom flask containing sodium hydride. 
The reaction was stirred at room temperature until no bubbles are produced. The reaction 
flask was placed in a cooling bath of dry ice-acetone mixture (-78 °C). After the 
temperature was constant, 1.04 mL of a 2.5 M n-butyllithium hexane solution was added 
dropwise to the reaction flask using a syringe. The progress of the reaction was monitored 
by TLC. The TLC eluent was a mixed solution of ethyl acetate and hexane 1:2. After all 
the reactants were converted into intermediate products, 0.215 mL of dimethyl diselenide 
liquid was added dropwise to the reaction flask with a syringe. The progress of the reaction 
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was examined by TLC. After the reaction was completed, the reaction was quenched by 
the addition of 0.7 mL of saturated brine. The reaction solution was diluted with ethyl 
acetate, and washed with water to remove THF and other water-soluble impurities. The 
aqueous phase was extracted three times with ethyl acetate, the aqueous phase was 
discarded, and the organic phases were combined. The organic phase was washed three 
times with saturated brine and the aqueous phase was discarded. The organic phase is dried 
over anhydrous magnesium sulfate. After filtration and rotary evaporation, a crude product 
was gained. Further purification using a silica gel column yields a product of higher purity. 
The eluent of the silica gel column was a mixed solution of ethyl acetate and hexane 1:5. 
When purifying on a silica gel column, a base should be used to neutralize the silica gel. 
In addition, because dimethyl diselenide has a particularly pungent odor, the contact with 
the dimethyl diselenide reaction vessel is oxidized by using a bleaching agent. Selenium-
containing waste liquid should be collected in a specific container to avoid environmental 
pollution.  
The yield of this step is only 30%-40%. 
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2.1.2.2 Proposed mechanism 
 
Figure 2.5 Schematic diagram of the reaction mechanism for methyl selenium 
introduction reaction. 
 
The mechanism of this step is shown in Figure 2.5. First, sodium hydride removes 
active protons in the molecule. Then, n-butyllithium converts iodine at the 5-position of 
the base to lithium by a lithium-halogen exchange reaction. Currently, the carbon atom at 
the 5-position becomes a suitable nucleophilic reagent, and the methyl selenization reaction 
occurs in attacking dimethyl diselenide. Finally, during the quenching process by adding 
saturated brine, the molecules acquire protons and restore electrical neutrality. 
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2.1.3 Detritylation 
2.1.3.1 Experimental procedure 
 
Figure 2.6 The reaction equation of detritylation step. 
 
The reaction equation of the deprotection of 3’-DMTr-5’-TBDMS-5-Se-Thymidine 
(Compound 3) is shown in Figure. 2.6. 500 mg of Compound 3 was weighed into a 25 mL 
round bottom flask. The flasks were dried over high vacuum for 30 min. The flasks were 
purged with argon and an argon balloon was placed to maintain constant pressure and 
ensure an argon atmosphere during the reaction. Compound 3 was dissolved in 13 mL of 
anhydrous tetrahydrofuran. A round bottom flask containing the compound 3 
tetrahydrofuran solution was placed in an ice water bath. After the temperature was 
stabilized, 1.36 mL of a 1 M tetrabutylammonium fluoride solution in tetrahydrofuran was 
added dropwise to a round bottom flask containing the compound 3 tetrahydrofuran 
solution. The flask was removed from the ice water bath and stirred at room temperature 
for two hours. The progress of the reaction was monitored by TLC. The TLC eluent was a 
mixed solution of ethyl acetate and hexane 2:1. After completion of the reaction, the 
reaction was quenched by the addition of 0.7 mL of saturated brine. The reaction solution 
was diluted with ethyl acetate, and washed with water to remove THF and other water-
soluble impurities. The aqueous phase was extracted three times with ethyl acetate, the 
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aqueous phase was discarded and the organic phases were combined. The organic phase 
was washed three times with saturated brine, and the aqueous phase was discarded. The 
organic phase is dried over anhydrous magnesium sulfate. Filtration and rotary evaporation 
gave a crude product. Further purification using a silica gel column yields a product of 
higher purity. The eluent of the silica gel column was a 4% methanol-dichloromethane 
mixed solution. When purifying on a silica gel column, a base should be used to neutralize 
the silica gel.  
The yield of this step is about 80%. 
2.1.3.2 Proposed mechanism  
 
Figure 2.7 Schematic diagram of the mechanism of detritylation reaction. 
 
The mechanism of this step is shown in Figure 2.7. According to the nature of the 
silicon-fluorine bond stronger than the silicon-oxygen bond, the fluoride ion attacks the 
silicon atom to undergo a substitution reaction. The process of quenching the reaction by 
adding saturated brine to obtain a proton of oxygen anion finally leads to an electrically 
neutral hydroxyl group. 
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2.1.4 The synthesis of phosphoramidite 
2.1.4.1 Experimental procedure 
 
Figure 2.8 Chemical reaction equation for phosphoramidite synthesis. 
 
The reaction equation of the phosphoramidation of 3’-DMTr-5-Se-Thymidine 
(Compound 4) is shown in Figure. 2.8. 365 mg of Compound 4 was weighed into a 25 mL 
round bottom flask. The flasks were dried over high vacuum overnight. The flasks were 
purged with argon and an argon balloon was placed to maintain constant pressure and to 
ensure an argon atmosphere during the reaction. 318.7 μL of dimethylethylamine and 
180.77 mg of i-Pr2NP(Cl)CH2CH2CN were simultaneously added to the round bottom flask 
containing Compound 4 with a syringe. The reaction was stirred at room temperature for 
half an hour. The progress of the reaction was monitored by TLC. The TLC eluent was a 
mixed solution of ethyl acetate and hexane 2:1. After the reaction was completed, the 
solvent was evaporated to dryness using a rotary evaporator. The phosphoramidite solid 
crude product was dissolved in 4 mL of dichloromethane. 200 mL of hexane was placed in 
a 500 mL beaker, and a solution of the phosphorous amide solid crude product in 
dichloromethane was added dropwise with stirring. Stir for 10 minutes until the 
precipitated precipitates all adhere to the beaker cup wall. The supernatant was decanted 
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by decantation. The precipitated solid crude product was dissolved in dichloromethane and 
dried. Further purification using a silica gel column immediately gave a product of higher 
purity. The eluent of the silica gel column was a mixed solution of ethyl acetate and hexane 
1:1.5. When purifying on a silica gel column, a base should be used to neutralize the silica 
gel.  
The yield of this step is about 60%. 
2.1.4.2 Proposed mechanism 
 
Figure 2.9  Schematic diagram of the mechanism of the phosphoramidite synthesis 
reaction. 
 
The mechanism of this step is shown in Figure 2.9. The chlorine atom is a preferred 
leaving group, so the first step in the reaction is that the hydroxyl group attacks the 
phosphorus atom to undergo a substitution reaction. The resulting acidic protons are 
absorbed by dimethylethylamine, thereby causing the reaction to proceed in the forward 
direction. 
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2.2 Synthesis and Purification of the Selenium Nucleic Acids 
2.2.1 Solid phase synthesis of the nucleic acid with selenium modification 
Millions of oligonucleotides are synthesized and used in the laboratory every year 
in the world. For most applications, only a very small amount of DNA is needed. Moreover, 
the synthesis of oligonucleotides is mainly carried out at a scale below 40 nmol. This is 
enough for most biological and biochemical experiments. But for biophysical studies such 
as nuclear magnetic resonance and X-ray diffraction crystallography, more DNA (more 
than 10 μmol) needs to be prepared. In extreme cases, it is often required to achieve 
quantities of several kilograms for the preparation of drug molecules (e.g., antisense 
oligonucleotides). Solid phase synthesis of oligonucleotides has emerged. And almost 
exclusively fully automated solid phase synthesis can meet all of the above requirements73, 
74. 
2.2.1.1 Advantages of solid phase synthesis 
Solid phase synthesis is widely used in the synthesis of peptides, oligonucleotides, 
oligosaccharides and various combinatorial chemistries. Solid-phase chemical synthesis 
was invented by Bruce Merrifield in the 1960s, and he won the 1984 Nobel Prize in 
Chemistry. 
The starting reagent of the solid phase synthesis method is immobilized on a solid 
support in the reaction column and the filter, and other reaction reagents and solvents can 
freely pass through the reaction. Relative to solution synthesis, solid phase synthesis can 
use a relatively large amount of solution phase reagent to promote the reaction to proceed 
more quickly and thoroughly. Moreover, impurities and excess reagents are rinsed off so 
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no additional purification process is required after each step is completed. At the same time, 
the solid phase synthesis process can also be fully automated through a computer. 
2.2.1.2 Solid supports 
The solid support is an insoluble particle and usually has a particle size of 50-200 
μm. During the synthesis, oligonucleotides are attached to these particles. There are many 
different particles to choose from, but microporous glass (CPG) and polystyrene have 
proven to be the most suitable. 
2.2.1.2.1 Controlled-pore glass (CPG) 
Controlled-pore glass is chemically stable, does not absorb solvent swelling, and 
has deep pores that allow for oligonucleotide synthesis reactions. A glass support with a 
pore size of 500 Å is suitable for mechanical synthesis of short-chain oligonucleotides. 
However, when a 500 Å pore size vector is used to synthesize an oligonucleotide sequence 
of more than 40 bases in length, the yield of the synthesis decreases sharply. This is because 
the growing oligonucleotide strand blocks the micropores and prevents the reaction reagent 
from diffusing into the support. Although larger pore size matrices are more fragile, it is 
more appropriate to use controlled-pore glass with a pore size of up to 1000 Å when 
synthesizing oligonucleotide sequences of up to 100 bases in length. Moreover, for the 
synthesis of longer oligonucleotide sequences, it is even possible to use a vector with a 
pore size of 2000 Å. 
2.2.1.2.2 Polystyrene (PS) 
Highly cross-linked polystyrene beads have good hydrophobicity and thus higher 
oligonucleotide synthesis efficiency, especially at very low scales (eg 40 nmol). A solid 
phase carrier for the synthesis of a conventional oligodeoxynucleotide is usually prepared 
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by attaching 20-30 μmol of nucleoside per gram of the carrier. The efficiency of synthesis 
of higher loading oligonucleotides is significantly reduced. This is because the steric 
hindrance effect of the oligonucleotide strands adjacent to each other on the carrier 
increases as the load increases. However, polystyrene carriers with a loading of up to 350 
μmol / g are used in some applications, especially the synthesis of short-chain 
oligonucleotides. This also makes it possible to synthesize a large number of 
oligonucleotide sequences. 
2.2.1.3 The phosphoramidite method 
A variety of solution phase oligonucleotide synthesis methods have been developed 
over the years. From the early studies of the hydrogen phosphite and phosphotriester 
methods by Michelson and Todd in the 1950s75, 76, and the attempt of Khorana to the 
phosphodiester method77, the re-study of the phosphotriester method and the development 
of the phosphite triester method in the 1960s and 1970s78-83, all these methods have their 
own drawbacks. The phosphoramidite method pioneered by Marvin Caruthers in the early 
1980s combined with automated solid phase synthesis became the current universal 
choice82.  
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Figure 2.10 Schematic diagram of the process of DNA phosphoramidite solid phase 
synthesis. 
 
The phosphoramidite synthesis process is in the direction of synthesis from the 3'-
end to the 5'-end (opposite to the direction of DNA biosynthesis in the DNA replication 
process). After each synthesis cycle is completed, one nucleotide is attached. The 
phosphoramidite DNA synthesis involves a series of steps, as shown in Figure 2.16. In 
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general, DNA phosphoramidite solid phase synthesis can be divided into four steps: 
activation and coupling, capping, oxidation, and DMTr protection. After completing the 
four steps, one cycle is completed and the synthetic oligonucleotide strand is increased by 
one base. This is repeated until the final completion of the desired oligonucleotide sequence 
for synthesis. 
2.2.1.3.1 Detritylation of the support-bound 3’-nucleoside 
 
Figure 2.11 Schematic diagram of the reaction mechanism of DMTr protection 
under acid catalysis. 
 
At the very beginning of the synthesis of the oligonucleotide strand, a nucleoside 
protected by a protecting group has been attached to the vector. A DNA synthesis column 
containing one of the four nucleosides A, C, G, and T is selected based on the nucleoside 
of the 3'-end of the desired DNA molecule. The nucleoside attached to the carrier is 
protected by a DMTr group at the 5'-position to prevent the corresponding polymerization 
from occurring during the preparation of the carrier. Prior to synthesis, the DMTr 
protecting group must be removed to ensure that the synthesis of the oligonucleotide is 
possible. The mechanism of DMTr protection is shown in Figure 2.17. DMTr easily forms 
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stable carbon cations under acidic conditions. The DMTr carbon cation is orange in 
solution. 
2.2.1.3.2 Activation and coupling (first step) 
 
Figure 2.12 Schematic diagram of the reaction mechanism of the phosphoramidite 
activation and coupling step. 
 
After deprotection by DMTr, the nucleoside attached to the carrier is ready to react 
with the next base. The reaction form of the base is a nucleoside phosphoramidite monomer. 
A large excess of a mixed solution of acetonitrile (an excellent solvent in a nucleic acid 
synthesis reaction) corresponding to a nucleoside phosphoramidite monomer and an 
activator (tetrazole or a derivative thereof) is injected into a DNA synthesis column to 
participate in the reaction. The diisopropylamino group on the nucleoside phosphoramidite 
monomer is protonated by the activator to a good leaving group. The phosphorus atom 
adjacent to it quickly attacks and undergoes a substitution reaction than the hydroxyl group 
on the nucleoside attached to the carrier. A new phosphorus-oxygen bond is formed, 
resulting in a phosphite triester attached to the support, as shown in Figure 2.18. The 
nucleoside phosphoramidite monomer is quite stable in an inert gas environment. It can be 
stored in large quantities, shipped to all parts of the world and can be used for several 
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months in dry conditions. Only when the nucleoside phosphoramidite is protonated will it 
become active. 
2.2.1.3.3 Capping (second step) 
Although the efficiency of the coupling reaction is quite high (up to 99.5%), there 
is no guarantee that all of the nucleosides on the support will react with the 
phosphoramidite monomer. This means that a small amount of nucleoside remains on the 
carrier containing a 5'-terminal hydroxyl group which is not involved in the reaction. If left 
untreated, it is possible for these 5'-terminal hydroxyl groups to react with the injected new 
phosphoramidite monomer in the next coupling reaction. This results in the deletion of one 
base by the synthetic oligonucleotide strand, which corresponds to a deletion mutation in 
the target oligonucleotide strand. If these deletion mutations are left unchecked, they will 
accumulate as the number of cycles is accumulated, making the final product a complex 
mixture of multiple oligonucleotide strands. Most of them are erroneous genetic 
information and are very difficult to purify. This will ruin subsequent biochemical 
experiments. 
 
Figure 2.13 Schematic representation of the reaction mechanism of the 
phosphoramidite activation and coupling steps. The correct oligonucleotide sequence (top) 
and the oligonucleotide sequence lacking one base (below) are deleted due to deletion of 
the sixth thymine. 
 
The "capping" step is introduced after the end of the coupling reaction to protect 
the unreacted 5'-terminal hydroxyl group to avoid deletion mutations. Two capping 
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solutions were used in the synthesizer: acetic anhydride and N-methylimidazole (NMI). 
The two reagents (dissolved in tetrahydrofuran to which a small amount of pyridine was 
added) were first mixed in a DNA synthesizer and then injected into a synthesis column. 
The mixed solution of the electrophile rapidly acetylates the alcohol. The presence of 
pyridine ensures that the reaction is carried out under basic conditions to avoid the reaction 
of acetic anhydride with N-methylimidazole to produce an acidic material which could 
remove the trityl group. The formylation at the 5'-end ensures a smooth follow-up reaction. 
The mechanism of the acetylation reaction is shown in Figure 2.20. 
 
Figure 2.14 Schematic diagram of the reaction mechanism of the acetylation 
capping step during the synthesis of oligonucleotide sequences by the phosphoramidite 
method. 
 
2.2.1.3.4 Oxidation (third step) 
The phosphite triester formed in the coupling reaction is unstable under acidic 
conditions and must be converted to a more stable pentavalent phosphorus form prior to 
the next step of trichloroacetic acid (TCA) deprotection with DMTr. This is achieved by 
oxidation of iodine in the presence of water and pyridine. The reaction product 
phosphotriester is an effective DNA backbone protected by 2-propionitrile. The 
propionitrile group avoids unnecessary reactions that may occur on the phosphate group in 
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subsequent synthesis cycles. The mechanism of the oxidation reaction is shown in Figure 
2.21. 
 
Figure 2.15 Schematic diagram of the reaction mechanism of the phosphite triester 
oxidation step during the synthesis of the oligonucleotide sequence by the phosphoramidite 
method. 
 
In some DNA synthesizers, there is a capping step after the iodine oxidation 
reaction. Its purpose is to dry the carrier. Because the moisture contained in the residual 
oxidizing solution affects the subsequent coupling reaction. Excess water will react with 
the acetylating reagent acetic anhydride to form acetic acid and be washed away by a 
tetrahydrofuran-pyridine mixed solution. 
2.2.1.3.5 Detritylation (fourth step) 
After coupling, capping, and oxidation, the 5'-end DMTr protecting group of the 
oligonucleotide strand attached to the carrier needs to be removed to obtain a free hydroxyl 
group, so that the new phosphoramidite monomer can be neutralized in the next cycle. An 
even reaction occurs. The de-DMTr-protected reaction under trichloroacetic acid in 
dichloromethane was very rapid and quantitative. The detached DMTr carbon cation is 
orange and can absorb visible light with a wavelength of 495 nm. The intensity of this 
absorption is used to test the efficiency of the coupling reaction. Most commercial DNA 
synthesizers support the ability to monitor the efficiency of synthesis in real time by 
detecting and reporting the yield of each cycle of DMTr. 
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The cycle is repeated, adding one base per cycle to finally synthesize the desired 
oligonucleotide sequence. 
2.2.1.4 Synthesis of oligonucleotide sequence containing 5-seleno-modified 
thymidine using a DNA synthesizer 
Our laboratory used a 3400 DNA synthesizer from Applied Biosystems. 25.6 mg 
(1 μmol) of dG-CPG powder was weighed in four DNA synthesis columns, respectively. 
The four base injection vials of the DNA synthesizer were loaded with enough four 
phosphoramidite acetonitrile solutions. A sufficient 0.15 mol/L 5-position selenium-
modified thymidine phosphoramidite acetonitrile solution was placed in the No. 5 solution 
bottle. Set the synthesis procedure, the sequence of the synthesis column No. 1 is5'-
d(CCAAAGTTGC)-3'; the sequence of the synthesis column No. 2 is 5'-
d(GCAACTTTGG)-3'; the sequence of the synthesis column No. 3 is 5’-
d(CCAAAGT5TGC)-3’; The sequence of the synthesis column is 5'-5’-
d(GCAACTT5TGG)-3’. To facilitate subsequent purification procedures, DMTr 
protection was set up without taking off the last nucleoside. After the DNA was synthesized, 
it was blown dry, transferred to a 1.5 mL centrifuge tube, and stored in a -80 ̊C refrigerator. 
2.2.2 Deprotection and purification of the nucleic acid with selenium modified 
DNA that has just been synthesized from a DNA synthesizer is clearly not directly 
available for subsequent biochemical experiments. First, the synthetic oligonucleotide 
strand is also attached to the vector and a separate treatment from the vector is required. In 
addition, many nucleoside bases are protected by various groups and require deprotection. 
Furthermore, some short-chain oligonucleotide strands are inevitably produced during 
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DNA synthesis. Although they are capped, they still need to be removed to avoid 
unnecessary trouble for subsequent experiments. 
2.2.2.1 Principle of nucleic acid deprotection and purification 
2.2.2.1.1 Isolation of the oligonucleotide strand from the vector 
After the completion of the synthesis, the obtained 3'-end of the target 
oligodeoxynucleotide chain is also linked to a complex on a solid phase carrier. This 
complex must be stable during the synthesis of the solid phase oligonucleotide sequence, 
but at the end of the synthesis it is necessary to be able to separate under certain conditions. 
This complex is usually linked by succinyl. This connection structure can be separated by 
reacting at room temperature for 1 h under concentrated ammonia conditions. 
In some DNA synthesizers, the separation reaction can be automated. After the 
reaction, the ammonia solution containing the oligonucleotide chain was transferred to a 
glass bottle. The separation reaction can also be accomplished by manual manipulation. 
2.2.2.1.2 Deprotection of oligonucleotide strands 
The oligonucleotide strand dissolved in aqueous ammonia requires heat to remove 
the heterocyclic base and the protecting group on the phosphate. Water and some volatile 
components are then removed by lyophilization. The next step is to purify the 
oligonucleotide strand. 
2.2.2.1.3 Deprotection of heterocyclic bases 
The primary amino group outside the ring of the heterocyclic base (A, C and G) is 
a nucleophile and therefore must be protected prior to the DNA synthesis reaction. The 
concentrated ammonia water used in the final deprotection treatment was reacted at 55 °C 
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for 5 hours to effectively remove these protecting groups. The most commonly used 
protection groups for these heterocyclic bases are shown in Figure 2.25. 
 
Figure 2.16 Schematic diagram of the protective group structure of adenosine, 
cytidine and guanosine commonly used in the synthesis of oligonucleotide sequences by 
phosphoramidite solid phase synthesis. 
 
The benzoyl protection on A and C is easily removed under aqueous ammonia 
conditions. However, the isopropyl formyl protection on G is more stable, so the final step 
of the deprotection reaction of the oligonucleotide chain is the reaction in which the 
isopropyl formyl group is removed on G. In the case of synthesizing a chemically modified 
oligonucleotide sequence, heating in aqueous ammonia may result in decomposition of the 
compound. Thus, in this case, a more unstable guanosine protecting group is required. The 
most popular active group protected guanosine is dimethylformamide guanosine (DMF 
dG). This guanosine makes it possible to deprotect the oligonucleotide chain under 
relatively mild conditions (reaction at 55 ºC in concentrated aqueous ammonia for 1 hour). 
49 
2.2.2.1.4 Deprotection of the phosphate backbone 
The phosphate group is always protected by the 2-propionitrile group during the 
synthesis, so deprotection is also required after the reaction is completed. The propionitrile 
group can be quickly removed under concentrated aqueous ammonia conditions. Since the 
cyano group has a strong electron withdrawing property, the hydrogen atom on its adjacent 
carbon atom thus exhibits a stronger acidity. The reaction was carried out in accordance 
with the β-elimination mechanism. 
 
Figure 2.17 A schematic diagram of the reaction mechanism for removing the 
propionitrile group protection on the phosphate triester after synthesizing the 
oligonucleotide sequence by the phosphoramidite method. 
 
2.2.2.2 Nucleic acid deprotection and purification steps 
To the synthesized DMTr-protected DNA-CPG carrier complex, 1 mL of 
concentrated aqueous ammonia was added, and the reaction was heated at 55 °C overnight. 
Transfer the supernatant to a 1.5 mL centrifuge tube A. The pellet was washed three 
times with 1 mL of 100 mg/mL sodium chloride solution, and the supernatant was 
transferred to a 1.5 Ml centrifuge tube B. The solutions of the centrifuge tubes A and B 
were repeatedly mixed so that the salt concentration in the final two centrifuge tubes was 
adjusted to 50 mg/mL. 
Take 0.1 mL of the sample solution and centrifuge to remove the solid support. 
Samples were analyzed using analytical HPLC. If the sample is relatively pure (the peak 
area ratio of the target DNA is >80%), and the subsequent experiment does not require 
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strict DNA purity, the DNA desalting column can be directly used for desalination 
treatment. Otherwise, the sample needs to be purified using preparative HPLC. 
The vacuum centrifuge was used for 1 h to remove most of the ammonia and some 
volatile impurities from the solution. Separation tests were first performed in preparative 
HPLC using a sample solution of about 5%. If the peak condition is normal, all samples 
are separated using preparative HPLC. The purified DNA solution needs to be purified by 
analytical HPLC. If the purity can meet the requirements of subsequent biochemical 
experiments, it should be prepared for DMTr protection after lyophilization. If the purity 
cannot meet the requirements of subsequent biochemical experiments, it needs to be re-run. 
purification. The DMTr protection was performed by dissolving the sample in 0.5 mL of 
ultrapure water and adjusting the pH to 4.5 using a 10% (v/v) aqueous solution of acetic 
acid. Heating at 40 ° C for 1 h. Samples were analyzed using analytical HPLC to ensure 
that the DMTr protecting groups of all DNA molecules were removed. If multiple peaks 
occur, purification by preparative HPLC is required once. Freeze to remove moisture and 
volatile impurities. The sample was dissolved in 1 mL of ultrapure water to prepare for salt 
removal. 
For the desalination treatment, the desalting column was treated with 1 mL of 
acetonitrile and 1 mL of 2 mol/L TEA·Ac aqueous solution. The sample is injected into a 
desalting column. The desalting column was then rinsed three times with ultrapure water, 
1 mL each time. Finally, the DNA was eluted from the desalting column using 1 mL of 30% 
aqueous acetonitrile. 
Freeze the sample. The DNA sample concentration was adjusted to 1 mmol/L using 
an ultraviolet-visible absorber. 
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2.3 Crystallization Procedure 
2.3.1 Introduction for Hanging Drop Vapor Diffusion Crystallization  
 
Figure 2.18 Hanging drop vapor diffusion crystallization 
 
Hanging drop vapor diffusion technology is a useful method for macromolecular 
crystallization. The principle of vapor diffusion is simple. The droplets consisting of a 
mixture of sample and reagent are equilibrated with the liquid reagent container vapor. 
Typically, the droplets contain a lower concentration of reagent than the reservoir. In order 
to reach equilibrium, the water vapor leaves the water droplets and eventually reaches the 
reservoir. As the water leaves the water droplets, the relative supersaturation of the sample 
increases. As the water leaves the reservoir, the concentration of both the sample and the 
reagent increases. Equilibrium is reached when the concentration of the reagent in the 
droplet is approximately the same as the concentration of the reagent in the reservoir.84 
There are pretty advantages for hanging drop vapor diffusion method. First, it can 
be cost effective. We only need 1 μL of sample for each screening try. Second, the sample 
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and reagents are in contact with a siliconized glass surface. The hydroxy groups in the glass 
may accelerate the crystallization process. Third, when we want to access the crystal, it can 
be straightforward. We only need to uncover the slide and mount the crystal. Last but not 
least, we can perform multiple drops (experiments) with a single reservoir. The glass is 
large enough to contain several sample drops simultaneously. It would cost even less, and 
the comparison could be very convenient. 
2.3.2 Sample Preparation 
Macromolecular samples should be homogeneous, as pure as possible (> 95%) and 
free of amorphous and particulate materials. The amorphous material is removed by 
centrifugation or microfiltration before use. If necessary, we can use HPLC to purify the 
sample. 
The recommended sample concentration is 5 to 25 mg/mL in deionized water. 
Initially, the sample should be free of any unnecessary additives to observe the effects of 
the Crystal Screen variable. Ideally, the initial screening should be performed with a sample 
that has been dialyzed against water, although the ligand, ion, reducing agent or other 
additive required for the sample may be soluble, stable or active.84 
2.3.3 Crystallization 
Firstly, using a clean pipet tip, pipet 1.0 milliliter of crystallization reagent into 
reservoir A1 of the Hampton Research VDX Plate. The recommended reservoir volume is 
0.5 to 1.0 milliliters. 
Then, clear a Siliconized 22 mm Circle or Square Cover Slide by wiping the cover 
slide with lens paper and blowing the cover slide with clean, dry compressed air. Pipet 2 
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microliter of the sample into the center of a Siliconized 22 mm Circle or Square Cover 
Slide. The recommended total drop volume is 2 to 20 microliters. 
Next, pipet 2 microliters of reagent from reservoir A1 into the drop on the cover 
slide containing the sample. 
Holding the cover slide with tweezers, the Pen-Vac, or on the edge between our 
thumb and forefinger, carefully and without delay invert the cover slide, so the drop is 
hanging from the cover slide. 
Finally, position the cover slide onto the bead of grease on reservoir A1. Gently 
press the slide down onto the grease and twist the slide 45º to ensure a complete seal. 
Repeat for reservoirs 2 (A2) through 24 (D6).73 
2.4 Crystal and Structure Study of DND-small Molecule Complex 
Designing and preparing novel compounds that recognize specific mixed base 
sequences in nucleic acid sequences can make DNA a cellular receptor for therapeutic and 
biotechnological applications as well as gene-specific probes. For example, if a small 
molecule capable of binding to a DNA promoter is developed, regulation of the RNA 
transcription process can be achieved. According to the central rule, the synthesis of 
proteins is regulated accordingly. Using this idea can cure some diseases. The potential of 
gene-specific probes in this area is limitless. The small molecules DB2429 and DB2457 
can specifically recognize the presence of A·T base pairs and G·C base pairs in the DNA 
minor groove. The 5-position selenium atom is located in the major groove, and the 
structure of the DNA-small molecule complex can be obtained by X-ray diffraction 
crystallographic analysis to determine whether the small molecule will also interact with 
the DNA major groove position and how it acts.  
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Figure 2.19 Schematic diagram of the molecular structure of two small molecules 
DB2429 and DB2457. 
 
In this experiment, four DNA sequences were synthesized, in which two natural 
DNA sequences were: W1 5'-d(CCAAAGTTGC)-3' and W2 5'-d(GCAACTTTGG)-3'; the 
selenium-modified DNA sequences were also two: W3 5 '-d(CCAAAGT5- SeTGC)-3' and 
W4 5'-d(GCAACTT5- SeT GG)-3'. W1 and W3 are the same sequences. W2 and W4 are the 
same, as well. W1 and W2 are complementary. These four DNA sequences can be 
constructed into four double-stranded DNA molecules of W1-W2, W1-W4, W2-W3, and 
W3-W4. W1-W2 is natural DNA. W1-W4 and W2-W3 contain a single selenium-modified 
thymidine. W3-W4 contains two selenium-modifications. 
 
  
55 
3 RESULTS 
3.1 The Synthesis of 5-Se-T phosphorimidite Starting with 5-I-dU 
 
 
Figure 3.1 Schematic diagram of the synthetic route for the synthesis of 5'-
dimethoxytrityl-5-methylseleno-deoxyuridinephosphoramidite using 5-iodo-deoxyuridine 
as the starting reactant. 
 
The synthetic route of synthesizing 5'-dimethoxytrityl-5-methylseleno-
deoxyuridine phosphoramidite with deoxyuridine (dU) as the initial reactant is shown in 
Figure 3.1. There are 5 steps totally to synthesis phosphoramidite, including tert-
butyldimethylsilyl (TBDMS-) protection, introduction of methyl selenium, det-
butyldimethylsilyl protection and dimethoxytrityl (DMTr-) protection. An advantage of 
this method compared to the former route is that in the step of introducing methyl selenium, 
the group at the 5'-position changes from dimethoxytrityl group to tert-butyldimethylsilyl 
group. The steric hindrance is significantly smaller, which increases the efficiency of 
methyl selenization. 
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3.1.1 Tert-butyldimethylsilyl (TBDMS-) protection 
3.1.1.1 Experimental procedure 
 
Figure 3.2 The reaction equation for the tert-butyldimethylsilyl protection reaction. 
 
The reaction equation of the protection of 5-Iodo-dU (Compound 6) is shown in 
Figure 3.2. 1 g of compound 6 was mixed with 3.08 g of imidazole in a 100 mL round 
bottom flask. 3.4 g of TBDMS-Cl was placed in another 10 mL round bottom flask. The 
flasks were dried over high vacuum for 30 min. The flasks were purged with argon and an 
argon balloon was placed to maintain a constant pressure and to ensure an argon 
atmosphere during the reaction. TBDMS-Cl was dissolved in 26 mL of anhydrous DMF, 
and a DMF solution of TBDMS-Cl was added dropwise to a round bottom flask containing 
compound 6 and imidazole. The reaction was stirred at room temperature overnight. The 
progress of the reaction was monitored by TLC. The TLC developing solvent was a mixed 
solution of ethyl acetate and hexane 1:2. After the reaction was completed, the reaction 
was quenched by the addition of 0.7 mL of methanol. The reaction solution was diluted 
with ethyl acetate and washed with water to remove DMF and other water-soluble 
impurities. The aqueous phase was extracted three times with ethyl acetate, the aqueous 
phase was discarded, and the organic phases were combined. The organic phase was 
washed three times with saturated brine and the aqueous phase was discarded. The organic 
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phase is dried over anhydrous magnesium sulfate. After filtration and rotary evaporation, 
a crude product was gained. Further purification using a silica gel column yields a product 
of higher purity. The eluent of the silica gel column was a mixed solution of ethyl acetate 
and hexane 1:5. 
The yield of this step is about 90%. 
3.1.2 The introduction of methyl selenium 
3.1.2.1 Experimental procedure 
 
Figure 3.3 The reaction equation for introducing a methyl selenium reaction. 
 
The reaction equation of the selenium introduction to 3’,5’-diTBDMS-5-Iodo-dU 
(Compound 7) is shown in Figure 3.3. 900 mg of Compound 7 was weighed into a 100 mL 
round bottom flask. Another 59 mg of sodium hydride was weighed into another 50 mL 
round bottom flask. The flasks were dried over high vacuum for 30 min. The flasks were 
purged with argon and an argon balloon was placed in the reaction flask to maintain a 
constant pressure and to ensure an argon atmosphere during the reaction. The compound 7 
was dissolved in 20 mL of anhydrous tetrahydrofuran treated with sodium metal, and a 
solution of the compound 7 in tetrahydrofuran was added dropwise to a round bottom flask 
containing sodium hydride. The reaction was stirred at room temperature until no bubbles 
are produced. The reaction flask was placed in a cooling bath of dry ice-acetone mixture (-
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78 ° C). After the temperature was constant, 2.5 mL of a 2.5 mol/L hexane solution of n-
butyllithium was added dropwise to the reaction flask with a syringe. The progress of the 
reaction was monitored by TLC. The TLC developing solvent was a mixed solution of 
ethyl acetate and hexane 1:5. After all the reactants were converted into intermediate 
products, 0.53 mL of dimethyl diselenide liquid was added dropwise to the reaction flask 
with a syringe. The progress of the reaction was monitored by TLC. After the reaction was 
completed, the reaction was quenched by the addition of 0.7 mL of saturated brine. The 
reaction solution was diluted with ethyl acetate, and washed with water to remove THF 
and other water-soluble impurities. The aqueous phase was extracted three times with ethyl 
acetate, the aqueous phase was discarded and the organic phases were combined. The 
organic phase was washed three times with saturated brine and the aqueous phase was 
discarded. The organic phase is dried over anhydrous magnesium sulfate. After filtration 
and rotary evaporation, a crude product was gained. Further purification using a silica gel 
column yields a product of higher purity. The eluent of the silica gel column was a mixed 
solution of ethyl acetate and hexane 1:6.5. Because dimethyl diselenide has a certain 
pungent odor, it is oxidized by using a bleaching agent in contact with a dimethyl 
diselenium reaction container. Selenium-containing waste liquid should be collected in a 
specific container to avoid environmental pollution. 
The yield of this step is about 60%. 
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3.1.3 Detert-butyldimethylsilyl protection 
3.1.3.1 Experimental procedure 
 
Figure 3.4 The equation for detritylation reaction. 
 
The reaction equation of deprotection of 3’,5’-diTBDMS-5-Se-dU (Compound 8) 
is shown in Figure. 3.4. 490 mg of compound 8 was weighed into a 100 mL round bottom 
flask. The flasks were dried over high vacuum for 30 min. The flasks were purged with 
argon and an argon balloon was placed to maintain a constant pressure and ensure an argon 
atmosphere during the reaction. Compound 8 was dissolved in 20 mL of anhydrous 
tetrahydrofuran. A round bottom flask containing the compound 8 tetrahydrofuran solution 
was placed in an ice water bath. After the temperature was stabilized, 3.56 mL of a 1 mol/L 
tetrabutylammonium fluoride in tetrahydrofuran solution was added dropwise to a round 
bottom flask containing the Compound 8 tetrahydrofuran solution. The flask was removed 
from the ice water bath and stirred at room temperature for two hours. The progress of the 
reaction was monitored by TLC. The TLC developer was a 5% methanol in 
dichloromethane. After completion of the reaction, the reaction was quenched by the 
addition of 0.7 mL of saturated brine. The reaction solution was diluted with ethyl acetate, 
and washed with water to remove THF and other water-soluble impurities. The aqueous 
phase was extracted three times with ethyl acetate, the aqueous phase was discarded and 
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the organic phases were combined. The organic phase was washed three times with 
saturated brine and the aqueous phase was discarded. The organic phase is dried over 
anhydrous magnesium sulfate. Filtration and rotary evaporation gave a crude product. 
Further purification using a silica gel column yields a product of higher purity. The eluent 
of the silica gel column was 6% methanol in dichloromethane. 
The yield of this step is about 90%. 
3.1.4 Dimethoxytrityl (DMTr-) protection 
3.1.4.1 Experimental procedure 
 
Figure 3.5 Chemical reaction equation for dimethoxytrityl protecting reaction. 
 
The reaction equation of the tritylation of 5-Se-Thymidine (Compound 9) is shown 
in Figure. 3.5. 340 mg of compound 9 was mixed with 5 mg of 4-dimethylaminopyridine 
(DMAP) in a 25 mL round bottom flask. 538.74 mg DMTr-Cl was placed in another 25 
mL round bottom flask. The flasks were dried over high vacuum for 30 min. The flasks 
were purged with argon and an argon balloon was placed to maintain a constant pressure 
and to ensure an argon atmosphere during the reaction. The DMTr-Cl was dissolved in 6 
mL of anhydrous pyridine, and a pyridine solution of DMTr-Cl was added dropwise to a 
round bottom flask containing Compound 9 and DMAP using a syringe. The reaction was 
stirred at room temperature for 2 h. The progress of the reaction was examined by TLC. 
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The TLC developer was a 5% methanol in dichloromethane. After the reaction was 
completed, the reaction was quenched by the addition of 0.7 mL of saturated brine. The 
reaction solution was diluted with ethyl acetate and washed with water to remove DMF 
and other water-soluble impurities. The aqueous phase was extracted three times with ethyl 
acetate, the aqueous phase was discarded and the organic phases were combined. The 
organic phase was washed three times with saturated brine and the aqueous phase was 
discarded. The organic phase is dried over anhydrous magnesium sulfate. After filtration 
and rotary evaporation, a crude product was gained. Further purification using a silica gel 
column yields a product of higher purity. The eluent of the silica gel column was 1.5% 
methanol in dichloromethane. 
The yield of this step is about 80%. 
3.1.4.2 Proposed mechanism  
 
Figure 3.6 Schematic diagram of the mechanism of phosphoramidite synthesis 
reaction. 
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The reaction mechanism of this step is shown in Figure 3.6. First, DMAP replaces 
the chlorine atom of DMTr-Cl to become a better leaving group, thereby activating carbon 
atoms. Then, the hydroxyl group at the 3'-position of the sugar ring attacks the carbon atom 
to undergo a substitution reaction. The role of DMAP in the reaction process is the catalyst 
and proton acceptor. 
3.2 Solid Phase Synthesis of the Selenium Nucleic Acid 
Millions of oligonucleotides are synthesized and used in the laboratory every year 
in the world. For most applications, only a tiny amount of DNA is needed. Moreover, the 
synthesis of oligonucleotides is mainly carried out at a scale below 40 nmol. This is enough 
for most biological and biochemical experiments. But for biophysical studies such as 
nuclear magnetic resonance and X-ray diffraction crystallography, more DNA (more than 
10 μmol) needs to be prepared. In extreme cases, it is often required to achieve quantities 
of several kilograms for the preparation of drug molecules (e.g., antisense 
oligonucleotides). Solid phase synthesis of oligonucleotides has emerged. And almost 
exclusively fully automated solid phase synthesis can meet all of the above requirements73, 
74. 
3.2.1 Advantages of solid phase synthesis 
Solid phase synthesis is widely used in the synthesis of peptides, oligonucleotides, 
oligosaccharides, and various combinatorial chemistries. Solid-phase chemical synthesis 
was invented by Bruce Merrifield in the 1960s, and he won the 1984 Nobel Prize in 
Chemistry. 
The starting reagent of the solid phase synthesis method is immobilized on a solid 
support in the reaction column and the filter, and other reaction reagents and solvents can 
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freely pass through the reaction. Relative to solution synthesis, solid phase synthesis can 
use a relatively large amount of solution phase reagent to promote the reaction to proceed 
more quickly and thoroughly. Moreover, impurities and excess reagents are rinsed off so 
no additional purification process is required after each step is completed. At the same time, 
the solid phase synthesis process can also be fully automated through a computer. 
3.2.2 Solid supports 
The solid support is an insoluble particle and usually has a particle size of 50-200 
μm. During the synthesis, oligonucleotides are attached to these particles. There are many 
different particles to choose from, but microporous glass (CPG) and polystyrene have 
proven to be the most suitable. 
3.2.2.1 Controlled-pore glass (CPG) 
Controlled-pore glass is chemically stable, does not absorb solvent swelling, and 
has deep pores that allow for oligonucleotide synthesis reactions. A glass support with a 
pore size of 500 Å is suitable for mechanical synthesis of short-chain oligonucleotides. 
However, when a 500 Å pore size vector is used to synthesize an oligonucleotide sequence 
of more than 40 bases in length, the yield of the synthesis decreases sharply. This is because 
the growing oligonucleotide strand blocks the micropores and prevents the reaction reagent 
from diffusing into the support. Although larger pore size matrices are more fragile, it is 
more appropriate to use controlled-pore glass with a pore size of up to 1000 Å when 
synthesizing oligonucleotide sequences of up to 100 bases in length. Moreover, for the 
synthesis of longer oligonucleotide sequences, it is even possible to use a vector with a 
pore size of 2000 Å. 
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3.2.2.2 Polystyrene (PS) 
Highly cross-linked polystyrene beads have good hydrophobicity and thus higher 
oligonucleotide synthesis efficiency, especially at very low scales (eg 40 nmol). A solid 
phase carrier for the synthesis of a conventional oligodeoxynucleotide is usually prepared 
by attaching 20-30 μmol of nucleoside per gram of the carrier. The efficiency of synthesis 
of higher loading oligonucleotides is significantly reduced. This is because the steric 
hindrance effect of the oligonucleotide strands adjacent to each other on the carrier 
increases as the load increases. However, polystyrene carriers with a loading of up to 350 
μmol / g are used in some applications, especially the synthesis of short-chain 
oligonucleotides. This also makes it possible to synthesize a large number of 
oligonucleotide sequences. 
3.2.3 The phosphoramidite method 
A variety of solution phase oligonucleotide synthesis methods have been developed 
over the years. From the early studies of the hydrogen phosphite and phosphotriester 
methods by Michelson and Todd in the 1950s75, 76, and the attempt of Khorana to the 
phosphodiester method77, the re-study of the phosphotriester method and the development 
of the phosphite triester method in the 1960s and 1970s78-83, all these methods have their 
own drawbacks. The phosphoramidite method pioneered by Marvin Caruthers in the early 
1980s combined with automated solid phase synthesis became the current universal 
choice82.  
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3.3 High-Performance Liquid Chromatogram (HPLC) Analysis for Selenium 
Modified DNA Sequences 
3.3.1 Reverse phase HPLC procedure 
The HPLC equipment used in our lab is a Hewlett Packard Series 1100 HPLC 
System. The HPC column is Welch Materials, Inc. UltisilTM XB-C18 chromatographic 
column. It’s a reverse phase column. 
The mobile phase is a mixture of Buffer A and Buffer B. Buffer A is 20 mM 
triethylamine in acetic acid(TEA-Ac) in deionized water solution. Buffer B is 20 mM TEA-
Ac in water/acetonitrile (50%/50%) solution. The mobile phase composition gradient 
varies for DMTr-on or DMTR-off DNA analysis because of the polarity difference. 
 
Table 3.1 Mobile phase composition gradient for DMTr-on DNA sequences 
purification. 
Time B% 
0 5 
8 60 
12 100 
20 100 
 
Table 3.2 Mobile phase composition gradient for DMTr-off DNA sequences 
purification. 
Time B% 
0 5 
15 40 
17 100 
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20 100 
 
The retention time for ideal DNA is about 12 min while that for short oligo usually 
is 5 min. If we observe only one single peak at 12 min in the HPLC chromatogram, there 
is no short oligo but right DNA. 
 
67 
3.3.2 HPLC chromatogram for W3 (5 '-d(CCAAAGT5- SeTGC)-3') 
 
Figure 3.7 HPLC chromatogram of DNA sequence W3 containing only one 
selenium-modified thymidine. 
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3.3.3 HPLC chromatogram for W4 (5'-d(GCAACTT5 -SeT GG)-3') 
 
Figure 3.8 HPLC chromatogram of the DNA sequence W4 of all thymidine-
containing selenium-modified DNA. 
 
3.3.4 Summary 
The chromatograms are all single peaks, indicating that the DNAs after synthesis 
and purification don’t contain too many short oligos. We can do an mass spectra to make 
sure that our sample is pure enough for subsequent biochemical experiments. Besides, the 
absorption peak at a wavelength of 300 nm is still strong, indicating that the DNA molecule 
is indeed selenium modified. 
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3.4 Mass Spectra of Nucleic Acid 
3.4.1 MALDI(+)-TOF spectra of W1 (5'-d(CCAAAGTTGC)-3') 
 
Figure 3.9 MALDI-TOF(+) MS analysis of the DMTr-off DNA W1 (5’-d 
(CCAAAGTTGC)-3’). Average mass [M] = 3012.034. Calculated [M + H]+: 3013.041. 
Measured [M + H]+: 3006.158. 
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3.4.2 MALDI(+)-TOF spectra of W2 (5'-d(GCAACTTTGG)-3') 
 
Figure 3.10 MALDI-TOF(+) MS analysis of the DMTr-off DNA W2 (5’-d 
(GCAACTTTGG)-3’). Average mass [M] = 3043.046. Calculated [M + H]+: 3044.053. 
Measured [M + H]+: 3039.333. 
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3.4.3 MALDI(+)-TOF spectra of 5’-double overhang DNA (5’-
d(CGGCAACTTTGG)-3’) 
 
Figure 3.11 MALDI-TOF(+) MS analysis of the DMTr-off 5’-double overhang 
DNA (5’-d (CGGCAACTTTGG)-3’). Average mass [M] = 3630.429. Calculated [M + H]+: 
3631.436. Measured [M + H]+: 3628.923. 
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3.4.4 MALDI(+)-TOF spectra of 5’-double overhang DNA (5’-
d(CGCCAAAGTTGC)-3’) 
 
Figure 3.12 MALDI-TOF(+) MS analysis of the DMTr-off  5’-double overhang 
DNA (CGGCAACTTTGG). Average mass [M] = 3661.429. Calculated [M + H]+: 
3662.429. Measured [M + H]+: 3660.152. 
 
3660.152
1831.165
3535.461
2441.0921221.026 3331.065 3848.421
0.0
0.5
1.0
1.5
2.0
2.5
4x10
In
te
n
s
. 
[a
.u
.]
1000 1500 2000 2500 3000 3500
m/z
73 
3.4.5 MALDI(+)-TOF spectra of single selenium modified 5’-double overhang 
DNA (5’-d(CGGCAACTT(5-SeT)GG)-3’) 
 
Figure 3.13 MALDI-TOF(+) MS analysis of the DMTr-off single selenium modified 
5’-double overhang DNA (CGGCAACTT(5-SeT)GG). Average mass [M] = 3740.400. 
Calculated [M + H]+: 3741.400. Measured [M + H]+: 3739.581. 
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3.4.6 MALDI(+)-TOF spectra of double selenium modified 5’-double overhang 
DNA (5’-d(CGGCAACT(5-SeT)(5-SeT)GG)-3’) 
 
Figure 3.14 MALDI-TOF(+) MS analysis of the DMTr-off double selenium 
modified 5’-double overhang DNA (CGGCAACT(5-SeT)(5-SeT)GG).  Average mass [M] = 
3819.371. Calculated [M + H]+: 3820.371. Measured [M + H]+: 3818.136. 
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3.4.7 MALDI(+)-TOF spectra of triple selenium modified 5’-double overhang 
DNA (5’-d(CGGCAAC(5-SeT)(5-SeT)(5-SeT)GG)-3’) 
 
Figure 3.15 MALDI-TOF(+) MS analysis of the DMTr-off triple selenium modified 
5’-double overhang DNA (CGGCAAC(5-SeT)(5-SeT)(5-SeT)GG).  Average mass [M] = 
3898.342. Calculated [M + H]+: 3899.342. Measured [M + H]+: 3896.818. 
 
3.4.8 Summary 
The measured molecular ion peak is almost the same as the theoretical value 
obtained by calculation. According to the HPLC chromatogram and the MS spectra of the 
DNA, we can believe that the synthesized DNA molecules are correct, and the selenium 
modification is successful. Because the molecular ion peaks are pretty clear, our samples 
are pure enough to do the crystal study. 
3.5 Melting Study for Selenium Nucleic Acid 
Complementary DNA mixtures typically have two different conformations, a 
double-stranded structure, and a single-stranded structure. It is not difficult to speculate 
from the thermodynamic law that the DNA molecules are mainly in the form of double-
strand in the case of lower temperature, and the DNA molecules are mostly in a single-
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stranded way at a higher temperature and lower concentration. The process of breaking 
double-stranded DNA into single strands is known as DNA denaturation, or DNA 
denaturing. The melting temperature of DNA refers to the temperature at which 50% of 
DNA in a sample has denatured from double-stranded DNA to single-stranded DNA. The 
amount of strand separation, or melting, is measured by the absorbance of the DNA 
solution at 260nm. Nucleic acids absorb light at this wavelength because of the electronic 
structure in their bases, but when two strands of DNA come together, the close proximity 
of the bases in the two strands quenches some of this absorbance. When the two strands 
separate, this quenching disappears, and the absorbance rises 30%-40%. This is called 
Hyperchromicity. The Hypochromic effect is the effect of stacked bases in a double helix 
absorbing less ultra-violet light.85, 86 
3.5.1 Melting study for DNA double-strand 
A mixed buffer solution of pH=7.4, 50 mmol/L Tris-HCl, 100 mmol/L NaCl, and 
1 mmol/L EDTA was prepared. The four DNA sequences used in the experiments were all 
configured to 1 mmol/L. Add 988 μL of buffer solution to each of the four quartz cuvettes 
labeled 1, 2, 3, and 4, and add 6 μL of W1 to the 1 and 2 cuvettes respectively, 6 μL of W2 
to the 1 and 3 cuvettes, 6 μL of W3 to the 3 and 4 cuvettes, and 6 μL of W4 to the 2 and 4 
cuvettes. The concentration of DNA double strands in the four cuvettes was 6 μmol/L. 
Place the four cuvettes in the UV-Vis absorption tester in sequence. Slowly warm up to 
90ºC to melt, then cool down to 15ºC to ensure that the DNA is fully integrated into a 
double-stranded structure. Set the measured absorption wavelength to 260 nm, the 
measurement speed to 0.5ºC/min, the onset temperature to 25ºC, and the termination 
temperature to 95ºC. 
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Figure 3.16 Normalized thermal-denaturation curves of four DNA double-stranded 
molecules containing different numbers of selenium modifications. 
 
We can obtain not only the trending lines in Figure 3.16 by analyzing the melting 
study data but also the thermodynamic data, such as Tm and ΔTm. Tm is the temperature 
where the fraction ssDNA rate of change over temperature is the biggest. We regard the 
native DNA, W1-W2, as the standard. The Tm difference between the selenium modified 
DNA and native DNA is ΔTm. 
 
Table 3.3 The Tm and ΔTm data of the four DNA double-strands via melting study 
Sequence ID Tm/ºC ΔTm/ºC 
W1-W2 44.8 0 
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W1-W4 41.9 -2.9±0.1 
W2-W3 43.7 -1.1±0.1 
W3-W4 40.8 -4.0±0.2 
 
The Tm of the DNA double-strand decreases as the number of selenium-containing 
modified bases increases. However, the Tm difference isn’t very notable. The selenium 
modification affects the thermal stability of DNA double-strand but not too much. 
3.5.2 Melting study for DNA and DB2429 complex 
A mixed buffer solution of pH=7.4, 50 mmol/L Tris-HCl, 100 mmol/L NaCl, and 
1 mmol/L EDTA was prepared. The four DNA sequences used in the experiments were all 
configured to 1 mmol/L. Add 976 μL of buffer solution and 12 μL of 0.5 mmol/L DB2429 
solution to each of the four quartz cuvettes labeled 1, 2, 3, and 4, respectively, and add 6 
μL of W1 to the 1 and 2 cuvettes, 6 μL of W2 to the 1 and 3 cuvettes, 6 μL of W3 to the 3 
and 4 cuvettes, and 6 μL of W4 to the 2 and 4 cuvettes. The concentration of DNA double-
strands binding with small molecule in the four cuvettes was 6 μmol/L. Place the four 
cuvettes in the UV-Vis absorption tester in sequence. Slowly warm up to 90ºC to melt, then 
cool down to 15ºC  to ensure that the DNA is fully integrated into a double-stranded 
structure. Set the measured absorption wavelength to 260 nm, the measurement speed to 
0.5ºC /min, the onset temperature to 25ºC, and the termination temperature to 95ºC. 
79 
 
Figure 3.17 Normalized thermal-denaturation curves of four DNA double-stranded 
molecules containing different numbers of selenium modifications and small molecule 
DB2429 complexes. 
 
The method we calculate Tm and ΔTm of DNA binding with DB2429 is all the 
same as what we did for DNA double-strand only. 
Table 3.4 The Tm and ΔTm data of the four DNA double-strands binding with 
DB2429 via melting study 
Sequence ID Tm/ºC ΔTm /ºC 
W1-W2-DB2429 56.7 0 
W1-W4-DB2429 56.8 0.1±0.1 
W2-W3-DB2429 55.9 -0.8±0.1 
W3-W4-DB2429 55.8 -0.9±0.1 
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The Tm of the DNA double-stranded and small-molecule DB2429 complex are 
almost all the same. The thermal stability of the DNA double-stranded isn’t affect by 
selenium modification. The ΔTm of the double-stranded DNA binding with the small 
molecule is smaller than DNA alone. It can be inferred that DB2429 binding tightly at the 
DNA minor groove. 
3.5.3 Melting study for DNA and DB2457 complex 
A mixed buffer solution of pH=7.4, 50 mmol/L Tris-HCl, 100 mmol/L NaCl, and 
1 mmol/L EDTA was prepared. The four DNA sequences used in the experiments were all 
configured to 1 mmol/L. Add 976 μL of buffer solution and 12 μL of 0.5 mmol/L DB2457 
solution to each of the four quartz cuvettes labeled 1, 2, 3, and 4, respectively, and add 6 
μL of W1 to the 1 and 2 cuvettes, 6 μL of W2 to the 1 and 3 cuvettes, 6 μL of W3 to the 3 
and 4 cuvettes, and 6 μL of W4 to the 2 and 4 cuvettes. The concentration of DNA double-
strands binding with small molecule in the four cuvettes was 6 μmol/L. Place the four 
cuvettes in the UV-Vis absorption tester in sequence. Slowly warm up to 90ºC to melt, then 
cool down to 15ºC  to ensure that the DNA is fully integrated into a double-stranded 
structure. Set the measured absorption wavelength to 260 nm, the measurement speed to 
0.5ºC /min, the onset temperature to 25ºC, and the termination temperature to 95ºC. 
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Figure 3.18 Normalized thermal-denaturation curves of four DNA double-stranded 
molecules with different numbers of selenium modifications and small molecule DB2457 
complexes. 
 
The calculation of Tm and ΔTm of DNA binding with DB2457 is all the same as 
DNA binding with DB2429. 
Table 3.5 The Tm and ΔTm data of the four DNA double-strands binding with 
DB2457 via melting study 
Sequence ID Tm/ºC ΔTm /ºC 
W1-W2-DB2457 59.8 0 
W1-W4-DB2457 59.4 -0.4±0.1 
W2-W3-DB2457 59.9 0.1±0.1 
W3-W4-DB2457 59.3 -0.5±0.1 
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Similar to DB2429, the Tm of the DNA double-stranded and small-molecule 
DB2457 complex are also almost the same. The selenium modification doesn’t 
significantly change the melting temperature or alter the duplex structure. The ΔTm of the 
double-stranded DNA binding with the small molecule is smaller than DNA alone. It can 
be inferred that DB2457 binding tightly at the DNA minor groove. 
At the temperature range from 40 to 50ºC, there is a shoulder in the trending line. 
That might be the effect caused by the small molecule DB2457 released from the DNA 
double-strand which means that DB2457 binding with DNA is not as tight as DB2429. 
3.6 Crystallization and Structure Studies 
For crystal screening, 24 different buffers of Hampton Scientific's Nucleic Acid 
Mini Screen Kit reagent were used. The DNA double-strand concentration was 0.2 mmol/L 
in deionized water, and the small molecule concentration was 0.3 mmol/L in deionized 
water. 500 mL of 15% v/v MPD aqueous solution or 20% v/v MPD aqueous solution was 
first added to the crystallization vial during crystal screening. Then 0.5 μL of the DNA 
sample solution and 0.5 μL of the crystallization reagent were evenly mixed on the slide 
and inverted on the crystallizing cell. Crystal growth was observed every other day. 
3.6.1 Crystallization result for 5’-d(CCAAAGTTGC)-3’ and 5’-
d(GCAACTTTGG)-3’ double strand DNA sequence binding with a small 
molecule. 
As we talked at the very beginning, we synthesized 4 different DNA sequences, 
which are listed in the form below. W1 and W2 can form a native DNA double strand. W1 
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with W4 or W2 with W3 can form a DNA double strand with single selenium modified. 
W3 and W4 can form a double selenium modified DNA double strand. 
Table 3.6 DNA sequences we synthesized which can bind with the small molecule 
DB2429 and DB2457. 
DNA Sequences Sequence Name 
5’-d(CCAAAGTTGC)-3’ W1 
5’-d(GCAACTTTGG)-3’ W2 
5’-d(CCAAAGT5-SeTGC)-3’ W3 
5’-d(GCAACTT5-SeTGG)-3’ W4 
 
We used the synthesized DNA sequences alone or binding with small molecule 
trying to create some crystal to do the X-ray diffraction. The figures in the following are 
some of the crystals we obtained. 
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Figure 3.19 Experimental DNA crystals obtained. 
 
The crystal quality is scaled by its shape and size. The higher scores the crystal get, 
the more possibility to get useful diffraction data. Perfect crystal shall get 5 scores while 
poor crystal can only get 1. 
W3-W4 Scale: 2  
W2-W3-DB2429 Scale: 2 W3-W4-DB2429 Scale: 2 
W1-W2-DB2457 Scale: 2 
W1-W4-DB2429 Scale: 1 
W2-W3-DB2457 Scale: 1 
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From the crystal figure, the crystal is small and numerous, and the shape is irregular. 
We sent the crystals to do X-ray diffraction. Unfortunately, we didn't get useful X-ray 
diffraction data with those DNA sequences. Subsequent work will continue to optimize 
crystallization conditions for better crystals. 
3.6.2 Crystallization study for DNA sequences with 3’-position overhangs 
Since we cannot get good crystals, we tried to add a GC overhang at 3’-position for 
each DNA sequence. As the overhangs introduced, the DNA double-strand shall form a 
GC sticky end. The sticky end could connect two DNA double strands easily which may 
make it easier to form better crystals. The form below shows the DNA sequences we 
synthesized. 
Table 3.7 DNA sequences we synthesized which has a GC overhang at 3'-position. 
DNA Sequences Sequence Name 
5’-d(CCAAAGTTGCGC)-3’ Top 
5’-d(GCAACTTTGGGC)-3’ N 
5’-d(GCAAC5-Se TTTGGGC)-3’ S 
5’-d(GCAAC5-Se T5-Se TTGGGC)-3’ D 
5’-d(GCAAC5-Se T5-Se T5-SeTGGGC)-3’ T 
 
The Top sequence can form a double strand DNA with S, D or T. The newly formed 
DNA double-strand should contain single, double or triple selenium modified. 
Table 3.8 The DNA double brand could be formed by the synthesized DNA 
sequences. To be read vividly, the bottom sequence is presented in 3' to 5' direction and 
the GC overhangs are highlighted. 
Name DNA Double Brand Sequences 
N 5’-d(      CCAAAGTTGCGC)-3’ 
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3‘-d(CGGGTTTCAACG    )-5’ 
S 5-d(       CCAA      AGTTGCGC)-3’ 
3‘-d(CGGGTT(5-SeT)CAACG    )-5’ 
D 5’-d(      CCA      A       AGTTGCGC)-3’ 
3‘-d(CGGGT(5-SeT)(5-SeT)CAACG    )-5’ 
T 5’-d(      CC      A       A        AGTTGCGC)-3’ 
3‘-d(CGGG(5-SeT)(5-SeT)(5-SeT)CAACG    )-5’ 
 
However, we couldn’t get any good shape crystals by using these DNA sequences. 
Still, we did a screening test. The screening result is shown in the form below. 
Table 3.9 Screening result for the DNA double strands with 3'-overhangs. 
 
Although we didn’t have good crystal which can do the X-ray diffraction to finish 
the structure study, we can still come to the conclusion that DNAs with selenium modified 
could be easier to form crystals. As we can see in the table above, the more selenium atoms 
in the DNA double strand, the faster and the more crystal we observed. 
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3.6.3 Crystallization study for DNA sequences with 5’-position overhangs 
We cannot get better crystal with 3’-position GC overhangs. So, we had another 
trial with 5’-position overhangs. The sequences we synthesized were listed below. 
Table 3.10 DNA sequences we synthesized which has a GC overhang at 5'-position. 
DNA Sequences Sequence Name 
5’-d(CGCCAAAGTTGC)-3’ Top 
5’-d(CGGCAACTTTGG)-3’ N 
5’-d(CGGCAAC TT5-Se TGG)-3’ S 
5’-d(CGGCAAC T5-Se T5-Se TGG)-3’ D 
5’-d(CGGCAAC5-Se T5-Se T5-SeTGG)-3’ T 
 
The Top sequence can form a double strand DNA with S, D or T. The newly formed 
DNA double-strand should contain single, double, or triple selenium modified. 
Table 3.11 The DNA double brand could be formed by the synthesized DNA 
sequences. To be read vividly, the bottom sequence is presented in 3' to 5' direction and 
the GC overhangs are highlighted. 
Name DNA Double Brand Sequences 
N 5’-d(CGCCAAAGTTGC)-3’ 
3‘-d(      GGTTTCAACGGC)-5’ 
S 5-d(CGCC      AAAGTTGC)-3’ 
3‘-d(    GG (5-SeT)TTCAACGGC)-5’ 
D 5’-d(CGCC      A       AAGTTGC)-3’ 
3‘-d(      GG(5-SeT)(5-SeT)TCAACGGC)-5’ 
T 5’-d(CGCC      A       A        AGTTGC)-3’ 
3‘-d(      GG(5-SeT)(5-SeT)(5-SeT)CAACGGC)-5’ 
88 
 
N Scale: 3 N Scale: 4 
N + 2429 Scale: 3 N + 2429 Scale: 3.5 
S Scale: 3 S Scale: 3 
S + 2429 Scale: 3 S + 2429 Scale: 2.5 
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S + 2457 Scale: 3 S + 2457 Scale: 2.5 
D Scale: 3 D Scale: 2.5 
D + 2429 Scale: 2.5 D + 2429 Scale: 2.5 
D + 2457 Scale: 2.5 D + 2457 Scale: 3 
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We are happy to see that we got some good crystals when we introduced GC 
overhangs at 5’-position. We mounted the crystals and tried to do the X-ray diffraction 
experiment. However, we still didn’t get good data even if we use the crystals which have 
regular shapes. 
T Scale: 2.5 T Scale: 3 
T + 2429 Scale: 2 T + 2429 Scale: 2 
T + 2457 Scale: 2.5 T + 2457 Scale: 2.5 
Figure 3.20 Some good crystals we got by using 5'-position GC overhangs. 
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3.6.4 The effect on the crystallization of different MPD concentration. 
Table 3.12 The crystallization result for the single selenium modified DNA double-
strand with 5'-position GC overhangs. The MPD concentration is distributed from 20% to 
45%. The pictures are what the crystals looked like on the third day. 
 
 
Table 3.13 The crystallization result for the single selenium modified DNA double-
strand with 5'-position GC overhangs binding with small molecule DB2429. The MPD 
concentration is distributed from 20% to 45%. The pictures are what the crystals looked 
like on the third day. 
 
 
Table 3.14 The crystallization result for the single selenium modified DNA double-
strand with 5'-position GC overhangs binding with small molecule DB2457. The MPD 
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concentration is distributed from 20% to 45%. The pictures are what the crystals looked 
like on the third day. 
 
 
Table 3.15 The crystallization result for the double selenium modified DNA double-
strand with 5'-position GC overhangs. The MPD concentration is distributed from 20% to 
45%. The pictures are what the crystals looked like on the third day. 
 
 
Table 3.16 The crystallization result for the double selenium modified DNA double-
strand with 5'-position GC overhangs binding with small molecule DB2429. The MPD 
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concentration is distributed from 20% to 45%. The pictures are what the crystals looked 
like on the third day. 
 
 
Table 3.17 The crystallization result for the double selenium modified DNA double-
strand with 5'-position GC overhangs binding with small molecule DB2457. The MPD 
concentration is distributed from 20% to 45%. The pictures are what the crystals looked 
like on the third day. 
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Table 3.18 The crystallization result for the triple selenium modified DNA double-
strand with 5'-position GC overhangs. The MPD concentration is distributed from 20% to 
45%. The pictures are what the crystals looked like on the third day. 
 
 
Table 3.19 The crystallization result for the triple selenium modified DNA double-
strand with 5'-position GC overhangs binding with small molecule DB2429. The MPD 
concentration is distributed from 20% to 45%. The pictures are what the crystals looked 
like on the third day. 
 
 
Table 3.20 The crystallization result for the triple selenium modified DNA double-
strand with 5'-position GC overhangs binding with small molecule DB2457. The MPD 
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concentration is distributed from 20% to 45%. The pictures are what the crystals looked 
like on the third day. 
 
Through the screening result above, we can conclude that higher MPD 
concentration can form crystals easier and better. And the sequences with more Se-
modification can create crystal more easily. 
 
3.6.5 Summary 
Single overhang and double overhangs DNA can form better crystals than triple 
overhangs DNA. The 5’-overhang DNA can form better crystals than 3’-overhang DNA. 
Single overhang and double overhangs DNA can form better crystals than triple overhangs 
DNA. The 5’-overhang DNA can form better crystals than 3’-overhang DNA. Higher MPD 
concentration can form more crystals. The sequences with more Se-modification can form 
crystal more easily. 
After acquiring the DNA crystal, the structure can be determined by X-ray 
diffraction. The crystal structure of each DNA molecule can be obtained by analyzing the 
X-ray diffraction data.  
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However, although we sent the DNA crystals to do the X-ray diffraction, we didn’t 
get any useful diffraction data. 
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4 CONCLUSIONS 
The two major challenges in nucleic acid X-ray crystallography, crystallization and 
phasing determination, can be partially solved by introducing selenium modification into 
DNA. 5-Se-thymidine was successfully synthesized and incorporated into DNA 
oligonucleotides via solid-phase synthesis to facilitate the crystallization and phasing.  
Small molecule DB2429 and DB2457 were co-crystalized with Se-DNAs and nice 
crystals were obtained, which are better than the native crystals. 5’-d(CCAAAGTTGC)-3’ 
and 5’-d(GCAACTTTGG)-3’ duplex can crystallize but doesn’t have useful X-ray 
diffraction data even that it’s selenium modified. The complex of DNA duplex binding 
with small molecule doesn’t have good diffraction data, as well.  
The melting study reveals that the selenium modification has no signification 
perturbation to the DNA stability. 
Since we couldn’t get good structure data from the regular DNA double-strands 
(native and Se-modified) after the X-ray diffraction, we tried to introduce overhangs to the 
duplex through which we could get a sticky end. The 5’-overhang DNA can form better 
crystals than 3’-overhang DNA. Single overhang and double overhangs DNA can form 
better crystals than triple overhangs DNA. We also find out that higher MPD concentration 
can form more crystals quickly and 35% MPD aqueous solution shall be the best reservoir 
solution for crystallization. The sequences with more Se-modification can create crystal 
more efficiently which means that selenium atom in the DNA molecule affects 
crystallization. 
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After obtaining the DNA crystal, the structure can be determined by X-ray 
diffraction. The crystal structure of each DNA molecule can be obtained by analyzing the 
X-ray diffraction data. 
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APPENDICES  
Appendix A Nucleic Acid Mini Screen (NAM) 
The Nucleic Acid Mini Screen™ is an efficient screen formulated to assist in the 
determination of preliminary crystallization conditions of nucleic acid fragments. 
Using 1 to 4 mM oligonucleotide stock concentration the screen requires less than 
25 microliters of sample. 
The screen evaluates sample concentration, temperature, pH, monovalent cations, 
divalent cations, and polyamines. To complete the screen, one will need 1) HR2-118 
Nucleic Acid Mini Screen, a set of twenty-four, 1 milliliter volumes of reagent and 2) 35% 
v/v (+/-)-2-Methyl-2,4-pentanediol, the dehydrant for the reagent well / reservoir (available 
separately as HR2-863 35% v/v (+/-)-2-Methyl-2,4-pentanediol). 
The composition of the nucleic acid mini screen allows one to apply the formulation 
to other nucleic acids such as deoxy- and ribozymes, pseudoknots and tRNAs. 
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Figure A.0.1 Nucleic acids mini screen kit conditions. 
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Appendix B The Synthesis of the Nucleotide with an Extended Pyrimidine Ring 
Appendix B.1 Introduction 
By using uridine as the starting reactants, the 3‘,5’-TIPDS-biscyc-selenoate (TiOS) 
was synthesized via 4 steps. The 4 steps are TIPDS protection, adding Ms-leaving group, 
Boc-protection and selenium introduction. The newly synthesized biscyc-selenoate can be 
used to synthesis novel nucleotide with seven or more-member ring as the base group. This 
could be a very interesting research. There are many different small molecules we can use 
to extend the base group ring. For now, we introduced ethylene glycol to extend the ring. 
In the future, we may use many other interesting small molecules such as acetonitrile to 
get aromatic extended ring. We can even synthesis sequences containing the new 
nucleotide to figure out the interaction between conventional nucleotides. 
 
Figure B.2 Synthesis route of 5-MeSe-T-phosphorimidite from 5-I-dU. 
 
The synthesis route of biscyc-selenoate was shown in figure one. As we can see, 
there are 4 steps totally to synthesis the selenoate from uridine. Firstly, we use TIPDS 
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group to protect the 3’- and 5’-position hydroxy groups. Secondly, we use Ms-group as the 
leaving group at 2’-position. Then, Boc-group is added to protect the nitrogen atom in the 
pyrimidine ring. Finally, we introduce selenium into the molecule. 
Appendix B.2 TIPDS Protection 
Appendix B.2.1 Experimental procedure 
 
Figure B.3 TIPDS protection reaction. 
 
10 g uridine was dissolved in 250 mL pyridine (concentration is about 0.1 M). The 
solution was cooled with ice bath. 15 mL TIPDS-Cl was added dropwise. The reaction was 
stirred at room temperature overnight. The reaction process was detected by TLC (TLC 
condition methanol: methylene chloride=1:20). When there was no uridine spot in the TLC 
plate, pyridine was evaporated under reduced pressure. The residue was dissolved in DCM 
and washed with 3M HCl. Then washed with sat. NaHCO3 and brine. The solution was 
dried by MgSO4. Then concentrated by evaporator after filtration. Finally, purified by 
column (with the eluent of methanol: methylene chloride=1:100). 
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Appendix B.2.2 Proposed mechanism 
 
Figure B.4 The proposed mechanism of TIPDS protection reaction. 
 
The first step is an SN2 reaction. First, the oxygen atom in the 5’-hydroxy group 
attacks the silica atom in the TIPDS-Cl and the chloride atom will be substituted, therefore. 
The pyridine here will work as a base, which will take the proton released from the hydroxy 
group. Then, 3’-hydroxy will react with the other silica though the same mechanism and 
the ring shall be closed. 
Appendix B.3 Adding Ms-Leaving Group 
Appendix B.3.1 Experimental procedure 
 
Figure B.5 Ms-leaving group adding reaction. 
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6 g starting material 3’,5’-TIPDS-uridine was dissolved in 80 mL THF and 
cooled down to 0℃. 5.1 mL TEA was added into the solution. Then treated with 1.4 mL 
MsCl. Reaction will be finished in about 1 h. The reaction process was detected by TLC 
(TLC condition methanol: methylene chloride=1:50). When there was no starting material 
spot in the TLC plate, saturated NaCl solution was added to quench the reaction. The 
residue was dissolved in DCM and washed with water and brine. The aqueous layer was 
extracted by DCM. The organic layer was dried by MgSO4. Then concentrated by 
evaporator after filtration. Finally, purified by silica gel column (with the eluent of 
methanol: methylene chloride=1:100). 
Appendix B.3.2 Proposed mechanism 
 
Figure B.6 The proposed mechanism of Ms-leaving group adding reaction. 
 
As shown in Figure B.6, the mechanism of Ms-leaving group adding reation is 
addition-elimination. First, the hydrogen atom in the 2’-hydroxy group attacks the sulfur 
atom in the Ms-Cl and a hydroxide will be formed during the process. Next, the electron 
pair in the hydroxide reforms a double bond which eliminated the chloride. 
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Appendix B.4 Boc-Protection 
Appendix B.4.1 Experimental procedure 
 
Figure B.7 Boc-protection reaction. 
 
6.7 g starting material 2’-Ms-3’,5’-TIPDS-uridine and 1.4 g DMAP was dissolved 
in 60 mL THF. 3.3 mL TEA was injected into the flask. 4.1 mL (Boc)2O was injected. The 
reaction was stirred at room temperature for about 1 h. The reaction process was detected 
by TLC (TLC condition Methanol: Methylene Chloride=1:100). When there was no 
starting material spot in the TLC plate, the solvent was evaporated and redissolved in DCM. 
The residue was dissolved in DCM and washed with water and brine. The aqueous layer 
was extracted by DCM. The organic layer was dried by MgSO4. Then concentrated by 
evaporator after filtration. Finally, purified by silica gel (with the eluent of ethyl acetate: 
hexanes=1:7). 
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Appendix B.4.2 Proposed mechanism 
 
Figure B.8 The mechanism of the Boc-protection reaction. 
 
The mechanism of the Boc-protection reaction is shown in Figure B.8. As we can 
see, the DMAP here works as a catalyst. First, DMAP actives the (Boc)2O through an 
addition-elimination reaction. The actived Boc-group will react with the nitrogen through 
the reaction. 
Appendix B.5 Selenium Introduction 
Appendix B.5.1 Experimental procedure 
 
Figure B.9 Selenium introduction reaction. 
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The reaction was conducted under Ar protection. 0.3 mL Me2Se2 and 3 mL THF 
was injected into the round bottom flask. The flask was cooled down to -78℃ by dry using 
ice and acetone mixture. 0.7 mL n-BuLi was injected under -78℃, then the solution was 
warmed to room temperature. Keep stirring at r.t. for 15 min. 0.56 g starting material 1-N-
Boc-2’-Ms-3’,5’-TIPDS-uridine was dissolved in 3 mL THF and injected into the selenium 
solution. The mixture was stirred at r.t. for 15-30 min. The reaction process was detected 
by TLC (TLC condition Methanol: Methylene Chloride=1:50). When there was no starting 
material spot in the TLC plate, the reaction was quenched with brine. The residue was 
dissolved in DCM and washed with water and brine. The aqueous layer was extracted by 
DCM. The organic layer was dried by MgSO4. Then concentrated by evaporator after 
filtration. Finally, purified by silica gel column (with the eluent of ethyl acetate: 
hexanes=1:7). 
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Appendix B.5.2 Proposed mechanism 
 
Figure B.10 The proposed mechanism of the selenium introduction reaction. 
 
The reaction goes on by two steps. First, the dimethyl diselenide is cleaved by n-
butyl lithium. Methyl selenide could be formed through the reaction. Next, the methyl 
selenide attacks the carbonyl carbon at 6’-position. Through the electron transfer, the C-N 
bond is open and the 2’-oxygen gets a negative charge. The oxygen becomes a strong 
nucleophile, and the MsO-group is a very good leaving group. With an SN2 reaction, the 
bicyclic intermediate is created. Then the methyl selenide replace the boc-group. After we 
quench the reaction, the intermediate is hydrolyzed into the product. 
Appendix B.6 Ring Formation Reactions 
The methyl selenide group is a good leaving group, which make the carbonyl 
carbon in the selenide ester very electrophilic. In the meantime, the nitrogen atom in imide 
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group is supposed to be a nucleophile. If we have a small molecule which has both 
electrophilic and nucleophilic group. The nucleophilic group could react with selenide ester 
part while the electrophilic group with imide nitrogen. Though such reaction, we could 
achieve the ring formation reaction. 
Theoretically, all of the small molecule which contains both a good leaving group 
and a nucleophilic part should be applicable to the ring formation reaction. Acetonitrile is 
a very proper example. 
First, the pKa of acetonitrile is only 25, which means that in base condition, the 
methyl group might lose a proton and form a carbon cation. The carbon cation is pretty 
stable because of the resonance effect, which is shown in the picture below. Carbon cation 
can react with the selenide ester and replace the methyl selenide group as the role of a 
nucleophile. 
 
Figure B.11 The resonance structure for acetonitrile carbon anion. The carbon 
anion should be relatively stable because of the resonance effect. 
 
Second, as we know, though the resonance structure of the acetonitrile shown 
below, it’s conspicuous that the carbon in the carbon-nitrogen triple bond shall contain 
some positive charge. Then that carbon could be possible to react with the imide nitrogen 
in the TiOS molecule as an electrophile. 
 
Figure B.12 The resonance structure for acetonitrile. The cyan carbon contains 
partial positive charge, which makes it electrophilic. 
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Now we have the eligible small molecule, acetonitrile, which might finish the ring 
formation reaction. The probable reaction equation is shown as following. 
 
Figure B.13 Reaction equation of the ring formation reaction for the TiOS with 
acetonitrile. 
 
If the reaction goes on well and just reacts as what we assumed, we should get the 
ring expanded product finally. The reaction could be divided by two steps. First, in basic 
condition, the methyl group attacks the carbonyl carbon. Through addition-elimination 
reaction, the methyl selenide group is substituted. Second, the imide nitrogen attacks the 
cyan carbon, and the new expanded ring is formatted. 
The new product we shall get via TiOS react with acetonitrile isn’t perfect. The 
CH2 in the expanded ring blocked the conjugated electrons, which makes the ring not 
aromatic. It can be a solution if we transfer the methyl group into amino group or hydroxyl 
group. By doing so, the long pair elections in N or O can be conjugated with the other 
electrons in the ring. And the ring could be aromatic. 
Some of the examples are listed as reaction equations below. 
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Figure B.14 Reaction equation of the ring formation reaction for the TiOS with 
cyanamide. The electrons in the p orbitals could be conjugated to make the expanded ring 
aromatic. 
 
 
Figure B.15 Reaction equation of the ring formation reaction for the TiOS with 
cyanic acid. The electrons in the p orbitals could be conjugated to make the expanded ring 
aromatic. 
 
 
Figure B.16 Reaction equation of the ring formation reaction for the TiOS with 
cyanic acid. The electrons in the p orbitals might not be conjugated to make the expanded 
ring aromatic. 
 
The small molecules listed above are just some of the possible reagents to expand 
the ring. There are still a lot of alternative molecules for us to format the ring. As we talked 
a lot before, any molecule that has or could have both leaving group and nucleophilic part 
might be a good choice. 
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Appendix B.7 Ethylene glycol introduction reaction 
We tried with acetonitrile to format the ring before. However, there is no reaction 
even if we heat it up overnight. It’s a brand-new molecule we got and we don’t know very 
much of the properties. There is one thing we are certain is that the selenide ester can react 
with alcohol. 
So, we decided to use ethylene glycol to format the ring. The overall reaction is 
shown as following. 
 
Figure B.17 The overall reaction equations of the ring formation reaction for the 
TiOS with ethylene glycol. We shall get a novel nucleoside with nine-member-ring. 
 
The reaction contains 3 steps totally. First, the ethylene glycol reacts with selenide 
ester part. The methyl selenide group is substituted. In Compound 5, both hydroxy group 
and imide nitrogen are nucleophiles. We can protect the hydroxy group with mesyl group 
to make it a good leaving. Then, it should be possible to finish the ring formation reaction. 
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Appendix B.7.1 Experimental procedure 
 
Figure B.18 Ethylene glycol introduction reaction. 
 
0.4 g starting material Ti-OS was dissolved in 3 mL THF and 3 mL ethylene glycol. 
0.4 mL TEA was added into the solution. Keep stirring at 65℃ overnight. The reaction 
process was detected by TLC (TLC condition methanol: methylene chloride=1:4). When 
there was no Ti-OS spot in the TLC plate, the residue was dissolved in DCM and washed 
with water and brine. The aqueous layer was extracted by DCM. The organic layer was 
dried by MgSO4. Then concentrated by evaporator after filtration. Finally, purified by silica 
gel column (with the eluent of ethyl acetate: hexanes=1:1). 
Appendix B.7.2 Proposed mechanism 
 
Figure B.19 The mechanism of the ethylene glycol introduction reaction. 
 
The ethylene glycol introduction reaction is also an addition elimination reaction. 
The oxygen atom in the hydroxy group in ethylene glycol attacks the carbonyl carbon near 
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the selenium. Then, the electron pair on the hydroxide reform a carbonyl bond and the 
methyl selenide group is substituted. 
Appendix B.8 Ms-leaving group introduction reaction 
Appendix B.8.1 Experimental procedure 
 
Figure B.20 Ms-leaving group introduction reaction. 
 
0.1 g starting material Ti-OS-EGol was dissolved in 2 mL THF. 0.1 mL TEA was 
added into the solution. 0.02 mL MsCl was injected. The reaction was stirred at room 
temperature for about 1 h. The reaction process was detected by TLC (TLC condition 
methanol: methanol: methylene chloride=1:4). When there was no Ti-OS-EGol spot in the 
TLC plate, the residue was dissolved in DCM and washed with water and brine. The 
aqueous layer was extracted by DCM. The organic layer was dried by MgSO4. Then 
concentrated by evaporator after filtration. Finally, purified by silica gel column (with the 
eluent of ethyl acetate: hexanes=1:2). 
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Appendix B.9 The synthesis for the nucleotide with an extended pyrimidine ring 
 
Figure B.21The final step for the synthesis is a ring formation reaction. We have 
both nucleophile and electrophile in the molecule. And they are not too far away from each 
other. Theoretically, we can do the reaction finally. 
 
Now, we have already got 150 mg Ms-protected Ti-OS-EGol. There is only one 
step left to our final product. It’s a ring formation step, as the picture showing above. If 
everything is going on well, we shall get the novel eight-member ring nucleotide finally. 
It is possible to extend pyrimidine ring via TiOS intermediate. In fact, all of the 
small molecules which contain both a good leaving group and a nucleophilic part should 
be applicable to the ring formation reaction. Acetonitrile and a series of acetonitrile 
derivatives are suitable for the ring formation. However, despite we tried different basic 
condition, different solvent, and different temperature, there is still no reaction.  
To make the reaction easier, we tried ethylene glycol. After reacting overnight at 
65℃, we observed the first step reaction finally. Although we still haven’t done the ring 
formation reaction, we believe that we can make it finally and we will keep working on it. 
 
